<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Biol</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosbiol</journal-id>
<journal-title-group>
<journal-title>PLOS Biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1544-9173</issn>
<issn pub-type="epub">1545-7885</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pbio.3000161</article-id>
<article-id pub-id-type="publisher-id">PBIOLOGY-D-18-01447</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Glycobiology</subject><subj-group><subject>Glycosylamines</subject><subj-group><subject>Nucleosides</subject><subj-group><subject>Adenosine</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Hypothermia</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Hypothermia</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Nucleic acids</subject><subj-group><subject>RNA</subject><subj-group><subject>Uridine</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Glycobiology</subject><subj-group><subject>Glycosylamines</subject><subj-group><subject>Nucleosides</subject><subj-group><subject>Inosine</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological parameters</subject><subj-group><subject>Body temperature</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological parameters</subject><subj-group><subject>Body temperature</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Vascular medicine</subject><subj-group><subject>Blood pressure</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical compounds</subject><subj-group><subject>Alkaloids</subject><subj-group><subject>Caffeine</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Cardiology</subject><subj-group><subject>Heart rate</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Physiology and effects of nucleosides in mice lacking all four adenosine receptors</article-title>
<alt-title alt-title-type="running-head">Physiology of mice lacking all four adenosine receptors</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Xiao</surname>
<given-names>Cuiying</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Liu</surname>
<given-names>Naili</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8104-1493</contrib-id>
<name name-style="western">
<surname>Jacobson</surname>
<given-names>Kenneth A.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Gavrilova</surname>
<given-names>Oksana</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0426-9475</contrib-id>
<name name-style="western">
<surname>Reitman</surname>
<given-names>Marc L.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland, United States of America</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Mouse Metabolism Core, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland, United States of America</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Hasko</surname>
<given-names>György</given-names>
</name>
<role>Academic Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Columbia University, UNITED STATES</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">marc.reitman@nih.gov</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>1</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>3</month>
<year>2019</year>
</pub-date>
<volume>17</volume>
<issue>3</issue>
<elocation-id>e3000161</elocation-id>
<history>
<date date-type="received">
<day>7</day>
<month>12</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>7</day>
<month>2</month>
<year>2019</year>
</date>
</history>
<permissions>
<license xlink:href="https://creativecommons.org/publicdomain/zero/1.0/" xlink:type="simple">
<license-p>This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/" xlink:type="simple">Creative Commons CC0</ext-link> public domain dedication.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pbio.3000161"/>
<abstract>
<p>Adenosine is a constituent of many molecules of life; increased free extracellular adenosine indicates cell damage or metabolic stress. The importance of adenosine signaling in basal physiology, as opposed to adaptive responses to danger/damage situations, is unclear. We generated mice lacking all four adenosine receptors (ARs), <italic>Adora1</italic><sup><italic>−/−</italic></sup><italic>;Adora2a</italic><sup><italic>−/−</italic></sup><italic>;Adora2b</italic><sup><italic>−/−</italic></sup><italic>;Adora3</italic><sup><italic>−/−</italic></sup> (quad knockout [QKO]), to enable investigation of the AR dependence of physiologic processes, focusing on body temperature. The QKO mice demonstrate that ARs are not required for growth, metabolism, breeding, and body temperature regulation (diurnal variation, response to stress, and torpor). However, the mice showed decreased survival starting at about 15 weeks of age. While adenosine agonists cause profound hypothermia via each AR, adenosine did not cause hypothermia (or bradycardia or hypotension) in QKO mice, indicating that AR-independent signals do not contribute to adenosine-induced hypothermia. The hypothermia elicited by adenosine kinase inhibition (with A134974), inosine, or uridine also required ARs, as each was abolished in the QKO mice. The proposed mechanism for uridine-induced hypothermia is inhibition of adenosine transport by uridine, increasing local extracellular adenosine levels. In contrast, adenosine 5′-monophosphate (AMP)–induced hypothermia was attenuated in QKO mice, demonstrating roles for both AR-dependent and AR-independent mechanisms in this process. The physiology of the QKO mice appears to be the sum of the individual knockout mice, without clear evidence for synergy, indicating that the actions of the four ARs are generally complementary. The phenotype of the QKO mice suggests that, while extracellular adenosine is a signal of stress, damage, and/or danger, it is less important for baseline regulation of body temperature.</p>
</abstract>
<abstract abstract-type="toc">
<p>A study of mice lacking all four adenosine receptors shows that while they mediate effects of uridine, inosine and adenosine, these receptors are dispensable for growth, metabolism, breeding, and body temperature regulation. This suggests that extracellular adenosine is a damage or danger signal, rather than a major regulator of baseline physiology.</p>
</abstract>
<abstract abstract-type="summary">
<title>Author summary</title>
<p>Elevated extracellular adenosine generally indicates metabolic stress or cell damage and regulates many aspects of physiology. We studied “QKO” mice lacking all four adenosine receptors. Young QKO mice do not appear obviously ill, but do show decreased survival later in life. QKO mice demonstrate that adenosine receptors are not required for growth, metabolism, breeding, and body temperature regulation. QKO mice are missing the pharmacologic effects of adenosine on body temperature, heart rate, and blood pressure. Therefore, all of these effects are mediated by the four adenosine receptors. We also determined that the hypothermic effects of a pharmacologic adenosine kinase inhibitor (A134974), uridine, or inosine each requires adenosine receptors. The uridine-induced hypothermia is likely due to its inhibition of adenosine uptake into cells. QKO mouse physiology appears to be the sum of the individual knockout mice, without evidence for synergy, indicating that the actions of the four adenosine receptors are generally complementary.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000062</institution-id>
<institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution>
</institution-wrap>
</funding-source>
<award-id>ZIA DK075063</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0426-9475</contrib-id>
<name name-style="western">
<surname>Reitman</surname>
<given-names>Marc L.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000062</institution-id>
<institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution>
</institution-wrap>
</funding-source>
<award-id>ZIA DK031117</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8104-1493</contrib-id>
<name name-style="western">
<surname>Jacobson</surname>
<given-names>Kenneth A.</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (ZIA DK075063; ZIA DK031117), <ext-link ext-link-type="uri" xlink:href="https://www.niddk.nih.gov/research-funding" xlink:type="simple">https://www.niddk.nih.gov/research-funding</ext-link>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="9"/>
<table-count count="3"/>
<page-count count="26"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>PLOS Publication Stage</meta-name>
<meta-value>vor-update-to-uncorrected-proof</meta-value>
</custom-meta>
<custom-meta>
<meta-name>Publication Update</meta-name>
<meta-value>2019-03-13</meta-value>
</custom-meta>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>The nucleoside adenosine is incorporated covalently into many molecules of life, including those involved in information archiving and translation, energy storage and use, regulation of gene expression and function, and intermediary metabolism. Free, extracellular adenosine levels are normally low, but are increased by cell damage and metabolic stressors, such as hypoxia and seizures. Elevated extracellular adenosine thus indicates danger or damage to tissues and elicits adaptive responses. These responses are typically adaptations to the danger state, including selective regulation of perfusion and dampening of (presumably excessive) inflammatory/immune responses. A central question in adenosine physiology is the contribution of adenosine to basal homeostasis versus its clear role in stressed states [<xref ref-type="bibr" rid="pbio.3000161.ref001">1</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref002">2</xref>].</p>
<p>Adenosine signals via four G protein–coupled adenosine receptors (ARs), A<sub>1</sub>AR, A<sub>2A</sub>AR, A<sub>2B</sub>AR, and A<sub>3</sub>AR. A<sub>1</sub>AR and A<sub>3</sub>AR are generally coupled to Gi, reducing cAMP and considered inhibitory, while A<sub>2A</sub>AR and A<sub>2B</sub>AR are typically coupled to Gs/Gq and are stimulatory, increasing cAMP/Ca<sup>++</sup> [<xref ref-type="bibr" rid="pbio.3000161.ref003">3</xref>]. AR activation causes a plethora of physiology, with some actions unique to one AR and others with contributions from multiple ARs.</p>
<p>Approved AR drugs include adenosine for paroxysmal supraventricular tachycardia (A<sub>1</sub>AR agonism), adenosine and regadenoson for myocardial perfusion imaging (A<sub>2A</sub>AR agonism, causing coronary artery vasodilation [<xref ref-type="bibr" rid="pbio.3000161.ref004">4</xref>]), istradefylline for Parkinson’s disease (A<sub>2A</sub>AR antagonism [<xref ref-type="bibr" rid="pbio.3000161.ref005">5</xref>]), and the nonselective AR antagonist theophylline for asthma. Caffeine, another nonselective AR antagonist, is found in coffee and certain medications for treatment of drowsiness, headache, or migraines. Selective AR ligands are being investigated for additional indications [<xref ref-type="bibr" rid="pbio.3000161.ref006">6</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref007">7</xref>]. Other drugs, such as dipyridamole and low-dose methotrexate, increase local adenosine levels, thus secondarily activating ARs.</p>
<p>One physiologic effect of adenosine is hypothermia [<xref ref-type="bibr" rid="pbio.3000161.ref008">8</xref>]. Adenosine-induced hypothermia was initially attributed to brain A<sub>1</sub>AR [<xref ref-type="bibr" rid="pbio.3000161.ref009">9</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref010">10</xref>], possibly through ARs in the nucleus of the solitary tract [<xref ref-type="bibr" rid="pbio.3000161.ref011">11</xref>] or preoptic area [<xref ref-type="bibr" rid="pbio.3000161.ref012">12</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref013">13</xref>]. A<sub>1</sub>AR may also regulate torpor (a hibernation-like state with hypothermia and reduced metabolism, heart rate, and respiration) [<xref ref-type="bibr" rid="pbio.3000161.ref014">14</xref>], but neither A<sub>1</sub>AR nor A<sub>3</sub>AR is required for fasting-induced torpor [<xref ref-type="bibr" rid="pbio.3000161.ref015">15</xref>]. Additionally, activation of mouse mast cell A<sub>3</sub>ARs also causes hypothermia [<xref ref-type="bibr" rid="pbio.3000161.ref016">16</xref>–<xref ref-type="bibr" rid="pbio.3000161.ref018">18</xref>], via histamine release and signaling through histamine H<sub>1</sub> receptors [<xref ref-type="bibr" rid="pbio.3000161.ref019">19</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref020">20</xref>]. Hypothermia is also caused by A<sub>2A</sub>AR agonists, which produce vasodilation, and by A<sub>2B</sub>AR agonists, which may be acting centrally [<xref ref-type="bibr" rid="pbio.3000161.ref021">21</xref>]. Thus, agonism of any of the four ARs can produce hypothermia.</p>
<p>It is unknown if adenosine also causes hypothermia by additional mechanisms. Could cellular uptake and phosphorylation of adenosine increase adenosine 5′-monophosphate (AMP)/ATP ratios, activating the energy sensor adenosine monophosphate–activated protein kinase (AMPK) [<xref ref-type="bibr" rid="pbio.3000161.ref022">22</xref>]? AMPK is proposed to have a role in signaling torpor/hypothermia [<xref ref-type="bibr" rid="pbio.3000161.ref023">23</xref>]. We produced <italic>Adora1</italic><sup><italic>−/−</italic></sup><italic>;Adora2a</italic><sup><italic>−/−</italic></sup><italic>;Adora2b</italic><sup><italic>−/−</italic></sup><italic>;Adora3</italic><sup><italic>−/−</italic></sup> mice (quad knockout [QKO] mice) to examine this idea and study the basal physiology and pathophysiology of mice lacking all four ARs.</p>
</sec>
<sec id="sec002" sec-type="results">
<title>Results</title>
<sec id="sec003">
<title>Producing QKO mice</title>
<p>QKO mice (<italic>Adora1</italic><sup><italic>−/−</italic></sup><italic>;Adora2a</italic><sup><italic>−/−</italic></sup><italic>;Adora2b</italic><sup><italic>−/−</italic></sup><italic>;Adora3</italic><sup><italic>−/−</italic></sup>) were produced by crossing the previously characterized individual AR knockout mice [<xref ref-type="bibr" rid="pbio.3000161.ref018">18</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref024">24</xref>–<xref ref-type="bibr" rid="pbio.3000161.ref026">26</xref>] as detailed in Mice in Materials and methods. The <italic>Adora1</italic><sup><italic>−</italic></sup> allele was slightly underrepresented in the progeny [<xref ref-type="bibr" rid="pbio.3000161.ref027">27</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref028">28</xref>], without pairwise interaction with genotype at the other three loci. QKO mice at 2 months of age appeared to breed normally, with litter sizes similar to controls (control, 9.8 ± 0.6 per litter, <italic>n</italic> = 11 litters versus QKO 9.6 ± 0.9 per litter, <italic>n</italic> = 5 litters; <italic>P</italic> = 0.85, unpaired <italic>t</italic> test). Breeding of 5-month-old QKO mice produced smaller litters (QKO litters of 1, 6, 3, and 7 pups versus control litters of 8, 9, 10, and 9 pups). In addition, the QKO mice showed decreased survival starting at about 15 weeks of age (<xref ref-type="fig" rid="pbio.3000161.g001">Fig 1A</xref>). Two independent lines of <italic>Adora1</italic><sup><italic>−/−</italic></sup> mice also show decreased survival (<ext-link ext-link-type="uri" xlink:href="https://www.jax.org/strain/014161" xlink:type="simple">https://www.jax.org/strain/014161</ext-link> and George Yuning Huang, National Institute of Diabetes and Digestive and Kidney Diseases, personal communication); to our knowledge, decreased survival has not been reported for <italic>Adora2a</italic><sup><italic>−/−</italic></sup>, <italic>Adora2b</italic><sup><italic>−/−</italic></sup>, or <italic>Adora3</italic><sup><italic>−/−</italic></sup> mice. The QKO mice exhibited some eye inflammation and dermatitis, like <italic>Adora2a</italic><sup><italic>−/−</italic></sup> mice (Dorian McGavern, National Institute of Neurological Disorders and Stroke, personal communication).</p>
<fig id="pbio.3000161.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.3000161.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Decreased survival of QKO mice with normal Tb and entry into torpor.</title>
<p>A. Kaplan–Meier survival of QKO (<italic>N</italic> = 43) and control (<italic>N</italic> = 45) mice, males and females. QKO survival is less than control, <italic>P</italic> = 0.0005 by Mantel–Cox test. B. QKO and control male mice show similar diurnal rhythm, and both groups enter torpor with a 24-hour fast. Data are means; SEMs omitted for visual clarity; <italic>N</italic> = 11–13/group. The numerical data are in Supporting information. QKO, quad knockout; Tb, core body temperature.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.g001" xlink:type="simple"/>
</fig>
<p>Growth, metabolism, and blood characteristics were measured in cohorts of male and female mice (summarized in <xref ref-type="table" rid="pbio.3000161.t001">Table 1</xref>). At 8–16 weeks of age, chow-fed mice had a slightly lower body weight due to reduced lean, but not fat, mass (<xref ref-type="supplementary-material" rid="pbio.3000161.s001">S1 Fig</xref> and <xref ref-type="supplementary-material" rid="pbio.3000161.s002">S2 Fig</xref>). These mice also showed improved glucose tolerance and lower serum free fatty acid, cholesterol, and insulin-like growth factor-1 (IGF-1) levels (<xref ref-type="supplementary-material" rid="pbio.3000161.s001">S1 Fig</xref> and <xref ref-type="supplementary-material" rid="pbio.3000161.s002">S2 Fig</xref>). Corticosterone levels were similar to controls with intact diurnal rhythm (control versus QKO: 8 AM 26.0 ± 5.2 versus 19.5 ± 4.3 ng/mL and 6 PM 149.6 ± 18.1 versus 103.9 ± 14.3 ng/mL; <italic>n</italic> = 10/group). Blood monocyte and polymorphonuclear leukocyte counts were reduced (<xref ref-type="supplementary-material" rid="pbio.3000161.s015">S1 Table</xref>). Serum chemistries revealed increased alkaline phosphatase and confirmed the low cholesterol levels (<xref ref-type="supplementary-material" rid="pbio.3000161.s016">S2 Table</xref>). On a high-fat diet, QKO mice were remarkably like control mice. An independent cohort of chow-fed older male mice was slightly heavier (body weight, white adipose tissue [WAT], brown adipose tissue [BAT], and liver, which likely accounts for the higher leptin and insulin; <xref ref-type="supplementary-material" rid="pbio.3000161.s017">S3 Table</xref>). In these mice, there was no difference in β-hydroxybutyrate or thyroxine (T4), while triiodothyronine (T3) was increased and corticosterone was reduced. Overall, QKO and control mice showed some phenotypic differences, which were generally neither striking nor present in all cohorts.</p>
<table-wrap id="pbio.3000161.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.3000161.t001</object-id>
<label>Table 1</label> <caption><title>Anatomic and metabolic characteristics of QKO mice.</title></caption>
<alternatives>
<graphic id="pbio.3000161.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Characteristics</th>
<th align="center">Female chow,</th>
<th align="center">Male chow,</th>
<th align="center">Male HFD,</th>
<th align="center">Male chow,</th>
</tr>
<tr>
<th align="center"/>
<th align="center">group housed</th>
<th align="center">singly housed</th>
<th align="center">singly housed</th>
<th align="center">singly housed</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center"/>
<td align="center"><italic><xref ref-type="supplementary-material" rid="pbio.3000161.s001">S1 Fig</xref></italic></td>
<td align="center"><italic><xref ref-type="supplementary-material" rid="pbio.3000161.s002">S2 Fig</xref></italic></td>
<td align="center"><italic><xref ref-type="supplementary-material" rid="pbio.3000161.s002">S2 Fig</xref></italic></td>
<td align="center"><italic><xref ref-type="supplementary-material" rid="pbio.3000161.s017">S3 Table</xref></italic></td>
</tr>
<tr>
<td align="right">Age:</td>
<td align="center"><italic>8–16 weeks</italic></td>
<td align="center"><italic>8–16 weeks</italic></td>
<td align="center"><italic>8–16 weeks</italic></td>
<td align="center"><italic>46 weeks</italic></td>
</tr>
<tr>
<td align="left"><bold>Body weight</bold></td>
<td align="center">⇩</td>
<td align="center">⇩</td>
<td align="center">no Δ</td>
<td align="center">⇧</td>
</tr>
<tr>
<td align="left"><bold>Fat mass</bold></td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center"/>
</tr>
<tr>
<td align="left"><bold>Lean mass</bold></td>
<td align="center">⇩</td>
<td align="center">⇩</td>
<td align="center">no Δ</td>
<td align="center"/>
</tr>
<tr>
<td align="left"><bold>Food intake</bold></td>
<td align="left"/>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center"/>
</tr>
<tr>
<td align="left"><bold>Energy expenditure</bold></td>
<td align="left"/>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center"/>
</tr>
<tr>
<td align="right">Age:</td>
<td align="center"><italic>17–19 weeks</italic></td>
<td align="center"><italic>17–19 weeks</italic></td>
<td align="center"><italic>17–19 weeks</italic></td>
<td align="center"/>
</tr>
<tr>
<td align="left"><bold>GTT AUC</bold></td>
<td align="center">⇩</td>
<td align="center">⇩</td>
<td align="center">no Δ</td>
<td align="center"/>
</tr>
<tr>
<td align="left"><bold>GTT insulin</bold></td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center"/>
</tr>
<tr>
<td align="left"><bold>ITT AUC</bold></td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center"/>
</tr>
<tr>
<td align="left"><bold>Glucose (non-fasting)</bold></td>
<td align="center">⇩</td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center">⇩</td>
</tr>
<tr>
<td align="left"><bold>Insulin (non-fasting)</bold></td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center">⇧</td>
</tr>
<tr>
<td align="left"><bold>Free fatty acids</bold></td>
<td align="center">⇩</td>
<td align="center">⇩</td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
</tr>
<tr>
<td align="left"><bold>Triglycerides</bold></td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
</tr>
<tr>
<td align="left"><bold>Cholesterol</bold></td>
<td align="center">⇩</td>
<td align="center">⇩</td>
<td align="center">no Δ</td>
<td align="center">⇩</td>
</tr>
<tr>
<td align="left"><bold>Leptin</bold></td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center">⇧</td>
</tr>
<tr>
<td align="left"><bold>Adiponectin</bold></td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
</tr>
<tr>
<td align="left"><bold>Insulin-like growth factor-1</bold></td>
<td align="center">⇩</td>
<td align="center">⇩</td>
<td align="center">no Δ</td>
<td align="center"/>
</tr>
<tr>
<td align="left"><bold>β-Hydroxybutyrate</bold></td>
<td align="left"/>
<td align="center"/>
<td align="center"/>
<td align="center">no Δ</td>
</tr>
<tr>
<td align="left"><bold>Corticosterone</bold></td>
<td align="left"/>
<td align="center"/>
<td align="center"/>
<td align="center">no Δ</td>
</tr>
<tr>
<td align="left"><bold>T3</bold></td>
<td align="left"/>
<td align="center"/>
<td align="center">no Δ</td>
<td align="center">⇧</td>
</tr>
<tr>
<td align="left"><bold>T4</bold></td>
<td align="left"/>
<td align="center"/>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
</tr>
<tr>
<td align="right">Age:</td>
<td align="center"><italic>37 weeks</italic></td>
<td align="center"><italic>32 weeks</italic></td>
<td align="center"><italic>24 weeks</italic></td>
<td align="center"><italic>46 weeks</italic></td>
</tr>
<tr>
<td align="left"><bold>Body length</bold></td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
</tr>
<tr>
<td align="left"><bold>BAT weight</bold></td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center">⇧</td>
</tr>
<tr>
<td align="left"><bold>Inguinal WAT weight</bold></td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center">⇧</td>
</tr>
<tr>
<td align="left"><bold>Gonadal WAT weight</bold></td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center">⇩</td>
<td align="center">no Δ</td>
</tr>
<tr>
<td align="left"><bold>Liver weight</bold></td>
<td align="center">no Δ</td>
<td align="center">⇩</td>
<td align="center">no Δ</td>
<td align="center">⇧</td>
</tr>
<tr>
<td align="left"><bold>Spleen weight</bold></td>
<td align="center">no Δ</td>
<td align="center">no Δ</td>
<td align="center">⇧</td>
<td align="center">no Δ</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>Primary data are in <xref ref-type="supplementary-material" rid="pbio.3000161.s001">S1 Fig</xref>, <xref ref-type="supplementary-material" rid="pbio.3000161.s002">S2 Fig</xref>, and <xref ref-type="supplementary-material" rid="pbio.3000161.s017">S3 Table</xref>. Arrows indicate significant changes (without multiplicity correction) in the indicated direction of the QKO mice; no Δ indicates no significant change. Abbreviations: AUC, area under the curve; BAT, interscapular brown adipose tissue; GTT, glucose tolerance test; HFD, high-fat diet; ITT, insulin tolerance test; QKO, quad knockout; T3, triiodothyronine; T4, thyroxine; WAT, white adipose tissue.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Kidney function (as assessed by serum creatinine and urea nitrogen, <xref ref-type="supplementary-material" rid="pbio.3000161.s016">S2 Table</xref>) were similar in control and QKO mice. Water intake was similar in control (3.71 ± 0.11 g/day, <italic>n</italic> = 16) and QKO (4.00 ± 0.28 g/day, <italic>n</italic> = 17; <italic>P</italic> = 0.36) mice. Necropsies of male, 32-week-old QKO and control mice (three of each) did not reveal any gross differences in the heart, lungs, liver, kidneys, spleen, gastrointestinal tract, testes, epididymis, seminal vesicles, urinary bladder, preputial gland, or brain. Similarly, no histological abnormalities were apparent in kidney (with tubular lipidosis in both control and QKO mice), heart, lung, spleen, WAT, or BAT.</p>
</sec>
<sec id="sec004">
<title>Normal body temperature and entry into torpor</title>
<p>Control and QKO male mice tolerated surgical implantation of intraperitoneal (i.p.) sensors for core body temperature (Tb) similarly (100% survival in 13 QKO and 12 controls). The light phase Tb, dark phase Tb, and Tb span, a measure of Tb variation, were the same in QKO and control mice (<xref ref-type="table" rid="pbio.3000161.t002">Table 2</xref>). Tb and activity had a similar diurnal rhythm in QKO and control mice, and all mice entered torpor when challenged with a 24-hour fast (<xref ref-type="fig" rid="pbio.3000161.g001">Fig 1B</xref>). QKO and control mice increased Tb and activity similarly in response to handling for food removal (<xref ref-type="fig" rid="pbio.3000161.g001">Fig 1B</xref>) or the stress of being placed in a cage previously occupied by an unfamiliar male. mRNA levels in WAT and BAT showed variable increases in Ucp1, but not Cidea or Cox8b (<xref ref-type="supplementary-material" rid="pbio.3000161.s018">S4 Table</xref>). These data indicate that ARs are not required for baseline control of Tb, induction of torpor, or bidirectional Tb regulation.</p>
<table-wrap id="pbio.3000161.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.3000161.t002</object-id>
<label>Table 2</label> <caption><title>Tb and physical activity in QKO and control mice.</title></caption>
<alternatives>
<graphic id="pbio.3000161.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Characteristics</th>
<th align="center">Control</th>
<th align="center">QKO</th>
<th align="center"><italic>P</italic></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left"><italic>N</italic></td>
<td align="center">11</td>
<td align="center">13</td>
<td align="center"/>
</tr>
<tr>
<td align="left">Body weight (g)</td>
<td align="center">24.36 ± 0.40</td>
<td align="center">23.55 ± 0.37</td>
<td align="center">0.16</td>
</tr>
<tr>
<td align="left">Tb, dark phase (°C)</td>
<td align="center">36.41 ± 0.11</td>
<td align="center">36.35 ± 0.06</td>
<td align="center">0.60</td>
</tr>
<tr>
<td align="left">Tb, light phase (°C)</td>
<td align="center">35.98 ± 0.11</td>
<td align="center">35.93 ± 0.10</td>
<td align="center">0.72</td>
</tr>
<tr>
<td align="left">Tb span (°C)</td>
<td align="center">2.46 ± 0.10</td>
<td align="center">2.38 ± 0.17</td>
<td align="center">0.71</td>
</tr>
<tr>
<td align="left">Activity, dark phase (beam breaks)</td>
<td align="center">17.83 ± 0.67</td>
<td align="center">16.15 ± 0.51</td>
<td align="center">0.06</td>
</tr>
<tr>
<td align="left">Activity, light phase (beam breaks)</td>
<td align="center">12.00 ± 0.73</td>
<td align="center">10.57 ± 0.51</td>
<td align="center">0.13</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>Data were obtained using G2 E-mitters and are mean ± SEM from a 72-hour time interval. Male mice were 12 weeks old. Tb span is the difference between the 5th and 95th percentiles and is a measure of Tb variation. <italic>P</italic> is from unpaired <italic>t</italic> tests, without correction for multiple tests.</p></fn>
<fn id="t002fn002"><p>Abbreviations: Tb, core body temperature; QKO, quad knockout.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec005">
<title>Blood pressure and heart rate</title>
<p>We investigated heart rate and blood pressure by telemetry in unanesthetized, freely moving female mice. Implantation of radio transmitters requires unilateral carotid artery occlusion; survival from this surgery was reduced in the QKO mice (5/11 [45%] QKO versus 34/42 [81%] non-QKO mice survived; <italic>P</italic> = 0.017 by χ<sup>2</sup>). The telemetered QKO mice had a higher light phase heart rate and lower dark phase blood pressure, but the small sample size limits the conclusions (<xref ref-type="table" rid="pbio.3000161.t003">Table 3</xref>). The usual diurnal effects (dark phase increases in systolic, diastolic, and mean arterial blood pressure (MAP), and in heart rate, Tb, and physical activity) were similar in QKO and control mice. Thus, ARs are not required for diurnal rhythmicity of blood pressure and heart rate.</p>
<table-wrap id="pbio.3000161.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.3000161.t003</object-id>
<label>Table 3</label> <caption><title>Baseline cardiovascular parameters in QKO and control mice.</title></caption>
<alternatives>
<graphic id="pbio.3000161.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" style="background-color:#D6DCE4"> Parameters</th>
<th align="center" style="background-color:#D6DCE4">Control dark</th>
<th align="center" style="background-color:#D6DCE4">QKO dark</th>
<th align="center" style="background-color:#D6DCE4"><italic>P</italic></th>
<th align="center" style="background-color:#D6DCE4">Control light</th>
<th align="center" style="background-color:#D6DCE4">QKO light</th>
<th align="center" style="background-color:#D6DCE4"><italic>P</italic></th>
</tr>
</thead>
<tbody>
<tr>
<td align="center"><italic>N</italic></td>
<td align="center">5</td>
<td align="center">5</td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="center">Heart rate (bpm)</td>
<td align="center">563 ± 17</td>
<td align="center">587 ± 18</td>
<td align="center">0.35</td>
<td align="center">505 ± 11</td>
<td align="center">558 ± 17</td>
<td align="center" style="background-color:#FFC7CE"><bold>0.031</bold></td>
</tr>
<tr>
<td align="center">Systolic (mmHg)</td>
<td align="center">128 ± 4</td>
<td align="center">117 ± 3</td>
<td align="center" style="background-color:#FFC7CE"><bold>0.047</bold></td>
<td align="center">111 ± 3</td>
<td align="center">108 ± 2</td>
<td align="center">0.46</td>
</tr>
<tr>
<td align="center">Diastolic (mmHg)</td>
<td align="center">100 ± 3</td>
<td align="center">91 ± 4</td>
<td align="center">0.11</td>
<td align="center">84 ± 2</td>
<td align="center">82 ± 3</td>
<td align="center">0.65</td>
</tr>
<tr>
<td align="center">MAP (mmHg)</td>
<td align="center">114 ± 3</td>
<td align="center">105 ± 3</td>
<td align="center">0.057</td>
<td align="center">98 ± 2</td>
<td align="center">96 ± 1</td>
<td align="center">0.47</td>
</tr>
<tr>
<td align="center">Tb (°C)</td>
<td align="center">37.06 ± 0.07</td>
<td align="center">36.68 ± 0.14</td>
<td align="center" style="background-color:#FFC7CE"><bold>0.041</bold></td>
<td align="center">35.82 ± 0.11</td>
<td align="center">36.01 ± 0.08</td>
<td align="center">0.20</td>
</tr>
<tr>
<td align="center">Activity (au)</td>
<td align="center">0.234 ± 0.061</td>
<td align="center">0.130 ± 0.023</td>
<td align="center">0.15</td>
<td align="center">0.072 ± 0.018</td>
<td align="center">0.061 ± 0.003</td>
<td align="center">0.59</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001"><p>Data are mean ± SEM from a 48-hour time interval of continuous recording during a quiet period in the animal facility, measured using HD-X11 transmitters in 24-week-old female mice. Analysis of the individual 12-hour epochs produced the same conclusions. <italic>P</italic> values are from unpaired <italic>t</italic> tests, without correction for multiple tests.</p></fn>
<fn id="t003fn002"><p>Abbreviations: au, arbitrary unit; bpm, beats per minute; MAP, mean arterial blood pressure; Tb, core body temperature.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec006">
<title>Loss of adenosine-induced hypothermia, bradycardia, and hypotension in QKO mice</title>
<p>Adenosine causes hypothermia in wild-type mice, via each of the four ARs. The 100 mg/kg dose of adenosine equals about 1/10th of the molar ATP content of the body, so instantaneous conversion of the adenosine (1 adenosine + 2 ATP → 3 ADP) would change a body’s ATP/ADP ratio from 10 to 2 and could signal an energy-depleted state, inducing hypothermia, independent of ARs. When male QKO mice were treated with adenosine, no hypothermia occurred. Similarly, treatment of female QKO mice with adenosine had no clear effect on Tb, heart rate, blood pressure, and activity, while in control mice, adenosine reduced Tb, heart rate, MAP, and activity and increased pulse pressure (<xref ref-type="fig" rid="pbio.3000161.g002">Fig 2A–2E</xref>). These results demonstrate that adenosine actions at A<sub>1</sub>AR, A<sub>2A</sub>AR, A<sub>2B</sub>AR, and/or A<sub>3</sub>AR mediate the full effects of adenosine-induced hypothermia, bradycardia, and hypotension. This result argues against the hypothesis that pharmacologic dosing of adenosine produces an AR-independent energy-depletion signal.</p>
<fig id="pbio.3000161.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.3000161.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Loss of cardiovascular effects of adenosine in QKO mice.</title>
<p>Female QKO and control mice were treated with adenosine (Ado, 100 mg/kg, i.p.) or vehicle (Veh). Adjusted <italic>P</italic> values (from two-way ANOVA with Sidak multiple comparisons test; <italic>N</italic> = 3–5/group) are for effect of vehicle versus adenosine in control mice; adenosine had no significant effect in QKO mice (<xref ref-type="supplementary-material" rid="pbio.3000161.s020">S6 Table</xref>). Activity data were analyzed after log transformation. The numerical data are in Supporting information. Ado, adenosine; au, arbitrary unit; bpm, beats per minute; i.p., intraperitoneal; MAP, mean arterial blood pressure; QKO, quad knockout; Tb, core body temperature; Veh, vehicle; WT, wild-type.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.g002" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec007">
<title>Response to lipopolysaccharide</title>
<p>Lipopolysaccharide (LPS) stimulates the innate immune system, increasing cytokine levels and causing Tb changes in a dose-dependent manner, with lower doses increasing Tb and higher doses causing hypothermia followed by fever [<xref ref-type="bibr" rid="pbio.3000161.ref029">29</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref030">30</xref>]. <italic>Adora2b</italic><sup><italic>−/−</italic></sup> mice are reported to have increased basal and LPS-stimulated cytokine levels [<xref ref-type="bibr" rid="pbio.3000161.ref031">31</xref>] and, pharmacologically, A<sub>2A</sub>AR [<xref ref-type="bibr" rid="pbio.3000161.ref032">32</xref>] and A<sub>3</sub>AR [<xref ref-type="bibr" rid="pbio.3000161.ref018">18</xref>] agonists inhibited LPS-induced cytokine production. We examined the QKO mice to see if their response to LPS was exaggerated. At a low dose (10 μg/kg, i.p.), LPS increased Tb slightly in control (Tb at 60–360 minutes versus vehicle: +0.52 ± 0.19°C, <italic>P</italic> = 0.018) and, similarly, in QKO (+0.58 ± 0.18°C, <italic>P</italic> = 0.007) mice. At a dose of 50 μg/kg, the QKO mice showed less (<italic>P</italic> = 0.015) increase in Tb in this interval (+0.89 ± 0.19°C, <italic>P</italic> = 0.0009 in control versus +0.31 ± 0.12°C, <italic>P</italic> = 0.023 in QKO). At a higher LPS dose (250 μg/kg, i.p.) the control mice demonstrated an increase in Tb, while the QKO mice had a mild early reduction in Tb, followed by a Tb increase (<xref ref-type="fig" rid="pbio.3000161.g003">Fig 3A–3E</xref>). These data are consistent with a subtly augmented Tb response to LPS in the QKO mice.</p>
<fig id="pbio.3000161.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.3000161.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Altered response to LPS in QKO mice.</title>
<p>Male QKO and control mice were treated with LPS (250 μg/kg, i.p.) or vehicle. Adjusted <italic>P</italic> values (from two-way ANOVA with Tukey multiple comparisons test; <italic>N</italic> = 11–12/group) are for effect of vehicle versus LPS within genotype (<xref ref-type="supplementary-material" rid="pbio.3000161.s020">S6 Table</xref>). The numerical data are in Supporting information. i.p., intraperitoneal; LPS, lipopolysaccharide; QKO, quad knockout; Tb, core body temperature; WT, wild-type.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.g003" xlink:type="simple"/>
</fig>
<p>We next studied the cytokine response to LPS (250 μg/kg, i.p.) at 2 hours after dosing. Of the 31 analytes with detectable levels, 24 increased upon treatment with LPS. Interestingly, there was no significant effect of genotype or genotype × treatment interaction on plasma levels of any of these 31 proteins (<xref ref-type="supplementary-material" rid="pbio.3000161.s019">S5 Table</xref>). Thus, in the QKO mice we observed neither a change in basal cytokine levels, nor an exaggerated cytokine response to LPS, suggesting that the innate immune system was not activated because of the lack of ARs.</p>
</sec>
<sec id="sec008">
<title>AMP-induced hypothermia occurs by AR-dependent and AR-independent mechanisms</title>
<p>AMP is a proposed natural regulator of torpor, and injection of large doses causes hypothermia [<xref ref-type="bibr" rid="pbio.3000161.ref033">33</xref>]. The contribution of ARs to AMP-induced hypothermia is debated [<xref ref-type="bibr" rid="pbio.3000161.ref015">15</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref034">34</xref>–<xref ref-type="bibr" rid="pbio.3000161.ref037">37</xref>]. In the QKO mice, the hypothermia caused by AMP (500 mg/kg, i.p.) was attenuated, but not abolished (<xref ref-type="fig" rid="pbio.3000161.g004">Fig 4A–4D</xref>). Thus, AMP-induced hypothermia has both AR-dependent and AR-independent components.</p>
<fig id="pbio.3000161.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.3000161.g004</object-id>
<label>Fig 4</label>
<caption>
<title>AMP causes less hypothermia in QKO mice compared with controls.</title>
<p>Male QKO and control mice were treated with AMP (500 mg/kg, i.p.) or vehicle. Adjusted <italic>P</italic> values (from two-way ANOVA with Tukey multiple comparisons test; <italic>N</italic> = 5–7/group) are (top) for effect of vehicle versus AMP within genotype or (bottom) effect of AMP between genotype (<xref ref-type="supplementary-material" rid="pbio.3000161.s020">S6 Table</xref>). The numerical data are in Supporting information. AMP, adenosine 5′-monophosphate; i.p., intraperitoneal; QKO, quad knockout; Tb, core body temperature; Veh, vehicle; WT, wild-type.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.g004" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec009">
<title>Adenosine kinase inhibition effects are via ARs</title>
<p>Adenosine kinase phosphorylates adenosine to AMP, keeping intracellular adenosine levels low, thereby drawing extracellular adenosine into cells down its concentration gradient. It has been suggested that inhibition of adenosine kinase causes hypothermia via AR-independent mechanisms [<xref ref-type="bibr" rid="pbio.3000161.ref038">38</xref>]. We confirmed that treatment of wild-type mice with the adenosine kinase inhibitor A134974 [<xref ref-type="bibr" rid="pbio.3000161.ref039">39</xref>] caused hypothermia in a dose-dependent manner (<xref ref-type="fig" rid="pbio.3000161.g005">Fig 5A–5D</xref>). In QKO mice, A134974 (5 mg/kg, i.p.) had no effect on heart rate, blood pressure, or Tb, while a 10-fold lower dose caused hypothermia, bradycardia, and hypotension in control mice (<xref ref-type="fig" rid="pbio.3000161.g005">Fig 5E–5I</xref>). These results suggest that the acute hypothermia and cardiovascular effects of adenosine kinase inhibition are due to increased extracellular adenosine acting on ARs, with no reason to invoke non-AR mechanisms.</p>
<fig id="pbio.3000161.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.3000161.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Tb and cardiovascular effects of adenosine kinase inhibition are due to ARs.</title>
<p>(A–D) Dose response of A134974 in male QKO and control mice. Smallest doses significantly different (one-way ANOVA with Dunnett multiple comparisons tests; <italic>N</italic> = 4–12/group) from vehicle were 0.1 mg/kg for Tb (0–60), 0.2 mg/kg for nadir Tb, and 0.05 mg/kg for activity (0–60). (E–I) Cardiovascular effects of A134974 in female QKO (5 mg/kg, i.p.) and control (0.5 mg/kg, i.p.) mice (<italic>N</italic> = 3–5/group; statistics in <xref ref-type="supplementary-material" rid="pbio.3000161.s020">S6 Table</xref>). The numerical data are in Supporting information. AR, adenosine receptor; au, arbitrary units; bpm, beats per minute; i.p., intraperitoneal; QKO, quad knockout; Tb, core body temperature; WT, wild-type.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.g005" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec010">
<title>Caffeine effects are lost in QKO mice</title>
<p>Caffeine is a brain-penetrant micromolar antagonist of all four human ARs [<xref ref-type="bibr" rid="pbio.3000161.ref040">40</xref>] and three of the mouse ARs (not A<sub>3</sub>AR) [<xref ref-type="bibr" rid="pbio.3000161.ref041">41</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref042">42</xref>]. Caffeine can also act at multiple other sites. In control mice, caffeine (30 mg/kg, i.p.) caused a prolonged increase in Tb, activity, and blood pressure, all of which were attenuated or lost in the QKO mice (<xref ref-type="fig" rid="pbio.3000161.g006">Fig 6A–6J</xref>). These data suggest that these actions of this dose of caffeine are mediated by ARs.</p>
<fig id="pbio.3000161.g006" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.3000161.g006</object-id>
<label>Fig 6</label>
<caption>
<title>Tb and activity effects of caffeine are lost in QKO mice.</title>
<p>(A-F) Male QKO and control mice were treated with caffeine (30 mg/kg, i.p.) or saline. Adjusted <italic>P</italic> values (from two-way ANOVA with Sidak multiple comparisons test; <italic>N</italic> = 11–12/group) are for effect of vehicle versus caffeine in control mice; caffeine effect was not significant in QKO mice. (G-J) Cardiovascular effects of caffeine (30 mg/kg, i.p.) or saline in female QKO mice (<italic>N</italic> = 3–5/group; statistics in <xref ref-type="supplementary-material" rid="pbio.3000161.s020">S6 Table</xref>). The numerical data are in Supporting information. au, arbitrary unit; bpm, beats per minute; i.p., intraperitoneal; MAP, mean arterial blood pressure; QKO, quad knockout; Tb, core body temperature; WT, wild-type.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.g006" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec011">
<title>Inosine causes hypothermia via mast cell A<sub>3</sub>AR</title>
<p>Inosine is formed by deamination of adenosine and has no known dedicated receptors, but has in vivo actions with multiple proposed mechanisms. Treatment of wild-type mice with inosine (200 mg/kg, i.p.) produced hypothermia and hypoactivity. Both effects were lost in the QKO mice (<xref ref-type="fig" rid="pbio.3000161.g007">Fig 7A–7D</xref>). The hypothermia was also lost in <italic>Kit</italic><sup><italic>W−sh/W−sh</italic></sup> mice, which lack mast cells (<xref ref-type="fig" rid="pbio.3000161.g007">Fig 7E–7H</xref>), and in <italic>Adora3</italic><sup><italic>−/−</italic></sup> but not <italic>Adora1</italic><sup><italic>−/−</italic></sup> mice (<xref ref-type="fig" rid="pbio.3000161.g007">Fig 7I and 7J</xref>). The most parsimonious explanation of the data is that inosine is acting on mast cell A<sub>3</sub>AR, causing mast cell activation, including histamine release and hypothermia [<xref ref-type="bibr" rid="pbio.3000161.ref019">19</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref043">43</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref044">44</xref>]. Inosine is probably not increasing extracellular adenosine by transporter inhibition [<xref ref-type="bibr" rid="pbio.3000161.ref045">45</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref046">46</xref>], as this would cause hypothermia via other ARs, in addition to A<sub>3</sub>AR (see below).</p>
<fig id="pbio.3000161.g007" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.3000161.g007</object-id>
<label>Fig 7</label>
<caption>
<title>Inosine causes hypothermia via adenosine receptor A<sub>3</sub>AR.</title>
<p>(A-D) Effect of inosine (200 mg/kg, i.p.) or saline in male QKO and control mice; <italic>N</italic> = 5–7/group. (E-H) Effect of inosine (200 mg/kg, i.p.) or saline in <italic>Kit</italic><sup><italic>W−sh/W−sh</italic></sup> and control mice. Adjusted <italic>P</italic> values (from two-way ANOVA with Tukey multiple comparisons test; <italic>N</italic> = 7/group) are for effect of vehicle versus inosine within genotype. (I-J) Effect of inosine (200 mg/kg, i.p.) or saline in control (WT), <italic>Adora1</italic><sup><italic>−/−</italic></sup> (A1 KO), <italic>Adora3</italic><sup><italic>−/−</italic></sup> (A3 KO), and <italic>Adora1</italic><sup><italic>−/−</italic></sup> <italic>Adora3</italic><sup><italic>−/−</italic></sup> (A1/3 DKO) mice. <italic>P</italic> values (paired <italic>t</italic> test) are for effect of vehicle versus inosine (<italic>N</italic> = 3–7/group; <xref ref-type="supplementary-material" rid="pbio.3000161.s020">S6 Table</xref>). The numerical data are in Supporting information. DKO, double knockout; i.p., intraperitoneal; KO, knockout; QKO, quad knockout; Tb, core body temperature; WT, wild-type.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.g007" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec012">
<title>Uridine-induced hypothermia requires ARs</title>
<p>A recent study found that plasma uridine levels decreased with feeding and increased with fasting and suggested that uridine was linked to the reduction in Tb during fasting [<xref ref-type="bibr" rid="pbio.3000161.ref047">47</xref>]. We replicated the effect of exogenous uridine (1,000 mg/kg, i.p.) to cause hypothermia in control mice. However, the uridine did not cause hypothermia in QKO mice (<xref ref-type="fig" rid="pbio.3000161.g008">Fig 8A–8D</xref>). The uridine-induced hypothermia was distinct from inosine-induced hypothermia, as it was intact in <italic>Adora1</italic><sup><italic>−/−</italic></sup> mice and attenuated but not eliminated in <italic>Adora3</italic><sup><italic>−/−</italic></sup>, <italic>Adora1</italic><sup><italic>−/−</italic></sup>;<italic>Adora3</italic><sup><italic>−/−</italic></sup>, and <italic>Kit</italic><sup><italic>W−sh/W−sh</italic></sup> mice (<xref ref-type="fig" rid="pbio.3000161.g008">Fig 8E–8J</xref>), suggesting action via A<sub>3</sub>AR and also A<sub>2A</sub>AR, and/or A<sub>2B</sub>AR.</p>
<fig id="pbio.3000161.g008" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.3000161.g008</object-id>
<label>Fig 8</label>
<caption>
<title>Uridine causes hypothermia via multiple ARs.</title>
<p>(A-D) Effect of uridine (1,000 mg/kg, i.p.) or saline in male QKO and control mice; <italic>N</italic> = 11–13/group. (E-H) Effect of uridine (1,000 mg/kg, i.p.) or saline in <italic>Kit</italic><sup><italic>W−sh/W−sh</italic></sup> and control mice. Adjusted <italic>P</italic> values (from two-way ANOVA with Tukey multiple comparisons test; <italic>N</italic> = 6/group) are for effect of vehicle versus uridine within genotype (<xref ref-type="supplementary-material" rid="pbio.3000161.s020">S6 Table</xref>). (I-J) Effect of uridine (1,000 mg/kg, i.p.) or saline in control (WT), <italic>Adora1</italic><sup><italic>−/−</italic></sup> (A1 KO), <italic>Adora3</italic><sup><italic>−/−</italic></sup> (A3 KO), and <italic>Adora1</italic><sup><italic>−/−</italic></sup><italic>;Adora3</italic><sup><italic>−/−</italic></sup> (A1/3 DKO) mice. <italic>P</italic> values (unpaired <italic>t</italic> test; <italic>N</italic> = 4–8/group) are for effect of vehicle versus uridine. The numerical data are in Supporting information. AR, adenosine receptor; DKO, double knockout; i.p., intraperitoneal; KO, knockout; QKO, quad knockout; Tb, core body temperature; WT, wild-type.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.g008" xlink:type="simple"/>
</fig>
<p>How does uridine cause hypothermia via the ARs? Uridine and adenosine are both substrates for the equilibrative nucleoside transporter 1 (ENT1), competing with each other for transport [<xref ref-type="bibr" rid="pbio.3000161.ref045">45</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref046">46</xref>]. An ENT1 inhibitor (6-S-[(4-Nitrophenyl)methyl]-6-thioinosine [NBMPR], 1 mg/kg, i.p.) had slight effects on Tb by itself, but greatly amplified the hypothermia caused by adenosine (100 mg/kg, i.p.) (<xref ref-type="fig" rid="pbio.3000161.g009">Fig 9A–9D</xref>). We identified a uridine dose (1,000 mg/kg, i.p.) with a modest effect on Tb and tested its effect on adenosine-induced hypothermia, finding an increased effect (<xref ref-type="fig" rid="pbio.3000161.g009">Fig 9E–9H</xref>). We next measured plasma adenosine in uridine-treated (2,000 mg/kg, i.p.) wild-type mice at 30 minutes after dosing, when uridine levels peak [<xref ref-type="bibr" rid="pbio.3000161.ref048">48</xref>]. Uridine levels were low (≤2 μM) in vehicle-treated controls and 3,360 ± 190 μM in uridine-treated mice (<xref ref-type="fig" rid="pbio.3000161.g009">Fig 9I</xref>); uridine treatment tended to increase plasma adenosine levels (0.842 ± 0.086 μM in vehicle-treated versus 1.33 ± 0.06 μM in uridine-treated mice; <italic>P</italic> = 0.08) (<xref ref-type="fig" rid="pbio.3000161.g009">Fig 9J</xref>). Taken together, these results suggest that uridine inhibits adenosine transporters such as ENT1, thereby increasing extracellular adenosine levels and causing hypothermia via mast cell A<sub>3</sub>AR and other ARs.</p>
<fig id="pbio.3000161.g009" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.3000161.g009</object-id>
<label>Fig 9</label>
<caption>
<title>Effect of treatment with ENT1 inhibitor or uridine on hypothermia.</title>
<p>(A-D) Effect of the ENT1 inhibitor, NBMPR (1 mg/kg, i.p.), or vehicle on adenosine (100 mg/kg, i.p.) hypothermia in C57BL/6J mice; <italic>N</italic> = 9–12/group. (E-H) Effect of uridine (1,000 mg/kg, i.p.) or saline on adenosine (100 mg/kg, i.p.) hypothermia in C57BL/6J mice. Adjusted <italic>P</italic> values (<italic>N</italic> = 5–9/group) are in <xref ref-type="supplementary-material" rid="pbio.3000161.s020">S6 Table</xref>. (I-J) Plasma uridine and adenosine levels 30 minutes after uridine (1,000 mg/kg, i.p.) or saline in C57BL/6J mice. <italic>P</italic> values (unpaired <italic>t</italic> test; <italic>N</italic> = 5–7/group) are for effect of uridine versus vehicle. The numerical data are in Supporting information. ENT1, equilibrative nucleoside transporter 1; i.p., intraperitoneal; NBMPR, 6-S-[(4-Nitrophenyl)methyl]-6-thioinosine; Tb, core body temperature.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.g009" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec013" sec-type="conclusions">
<title>Discussion</title>
<p>We generated QKO mice to examine adenosine physiology and test whether exogenous adenosine-induced hypothermia occurs independent of ARs, such as by energy depletion. For example, brain glucoprivation produces hypothermia [<xref ref-type="bibr" rid="pbio.3000161.ref049">49</xref>] and glucose and fatty acids levels are sensed in the hypothalamus [<xref ref-type="bibr" rid="pbio.3000161.ref050">50</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref051">51</xref>]. Specifically, AMPK is a cellular energy sensor and we hypothesized that uptake and phosphorylation of adenosine might trigger hypothermia such as via AMPK. While we cannot formally rule out complex multihit mechanisms requiring both ARs and non-AR mediators, the most parsimonious interpretation of the lack of adenosine-induced hypothermia in the QKO mice is that adenosine causes hypothermia via ARs and not by cellular energy depletion.</p>
<sec id="sec014">
<title>QKO and adenosine physiology</title>
<p>We were surprised by the baseline phenotype of mice lacking all ARs. We had hypothesized that QKO mice might have a basally activated immune system and not survive or be healthy. Young QKO mice turned out to be viable and breed readily. We did observe reduced blood monocyte and neutrophil levels, but we do not know the mechanism. Like <italic>Adora1</italic><sup><italic>−/−</italic></sup> mice (<ext-link ext-link-type="uri" xlink:href="https://www.jax.org/strain/014161" xlink:type="simple">https://www.jax.org/strain/014161</ext-link>), they showed decreased survival starting at about 4 months of age, with no identified cause of death. While the QKO mice showed no mortality from the surgery for i.p. implantation of Tb telemeters, they did exhibit increased mortality from surgery for cardiovascular telemeter implantation, which requires ligation of one carotid artery. A crucial difference is that carotid ligation is an ischemic event, increasing brain adenosine, which is neuroprotective via multiple ARs [<xref ref-type="bibr" rid="pbio.3000161.ref052">52</xref>]. These protective effects cannot occur in the QKO mice, confirming adenosine’s beneficial effects in certain “danger” situations.</p>
<p>While LPS treatment showed a subtly modified effect on Tb, the QKO mice had cytokine levels (basal and LPS-stimulated) that were the same as those in control mice. This differs from the reported elevated basal and LPS-stimulated TNF-α and IL-6 levels in <italic>Adora2b</italic><sup><italic>−/−</italic></sup> mice [<xref ref-type="bibr" rid="pbio.3000161.ref031">31</xref>]. Possible explanations for this difference include LPS dose, genetic background, and effect of the other AR genotypes. However, most literature on the role of ARs in modulating the LPS response examines the effect of exogenous drugs [<xref ref-type="bibr" rid="pbio.3000161.ref018">18</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref032">32</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref044">44</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref053">53</xref>], not of AR loss. Basal cytokine levels were reported unchanged with loss of A<sub>2A</sub>AR [<xref ref-type="bibr" rid="pbio.3000161.ref032">32</xref>] or A<sub>3</sub>AR [<xref ref-type="bibr" rid="pbio.3000161.ref018">18</xref>]. This evidence again suggests that adenosine is more important for “emergency physiology” in danger/damage situations, and not under basal conditions.</p>
<p>Adenosine physiology can be difficult to study. Adenosine, the natural ligand, is locally cleared in a few seconds [<xref ref-type="bibr" rid="pbio.3000161.ref054">54</xref>], with a plasma half-life of about 1 minute in humans [<xref ref-type="bibr" rid="pbio.3000161.ref055">55</xref>]. The rapid clearance means that experimentally, massive adenosine doses are used, with a complicated relationship to endogenous physiology. One solution is use of synthetic ligands, which increase the effect duration and likely provide supraphysiologic activation. It is not known if AR physiology from transient adenosine binding differs from the prolonged activation from agonist ligands. Some synthetic ligands are selective for one AR, but ligand selectivity can vary by &gt;1,000-fold between species [<xref ref-type="bibr" rid="pbio.3000161.ref041">41</xref>]. The use of knockout mice is a powerful tool for ensuring ligand selectivity, with loss of drug effect in the null being strong evidence for an “on-target” action, due to the identified AR. However, QKO mice develop from conception without any ARs, which may elicit compensatory mechanisms, underestimating the role of the missing AR. Therefore, a more prominent phenotype of the QKOs might appear in different experimental stress models. Finally, ARs can heterodimerize with other G protein-coupled receptors and use multiple signaling routes [<xref ref-type="bibr" rid="pbio.3000161.ref056">56</xref>], so it is possible that probing adenosine effect may require understanding of dimerization partners and differential effects on signaling pathways.</p>
</sec>
<sec id="sec015">
<title>Role of adenosine in hypothermia induced by various nucleosides and their modulators</title>
<p>The clear result that adenosine-induced hypothermia is absent in QKO mice makes these mice extremely valuable for investigating the possible role of adenosine in physiology thought to be caused by other agents. For example, the AR contribution to AMP-induced hypothermia is controversial [<xref ref-type="bibr" rid="pbio.3000161.ref015">15</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref034">34</xref>–<xref ref-type="bibr" rid="pbio.3000161.ref037">37</xref>]. The attenuation of AMP-induced hypothermia in the QKO mice demonstrates that both AR-independent and AR-dependent mechanisms contribute. Additionally, the QKO mice enable study of the non-AR mechanism.</p>
<p>In contrast, the QKO mice demonstrate that the acute hypothermia caused by an adenosine kinase inhibitor is completely attributable to ARs. Some of the hypothermia is due to the increased extracellular adenosine activating A<sub>1</sub>AR [<xref ref-type="bibr" rid="pbio.3000161.ref038">38</xref>]. While possible explanations for the remaining A134974-induced hypothermia have been proposed, the QKO results dictate that the non–A<sub>1</sub>AR-mediated hypothermia must occur via A<sub>2A</sub>AR, A<sub>2B</sub>AR, and/or A<sub>3</sub>AR.</p>
<p>Inosine does not have identified dedicated receptors. Mechanisms that might explain inosine’s neuroprotective and immunomodulatory actions include all four ARs and non-AR routes (reviewed in [<xref ref-type="bibr" rid="pbio.3000161.ref057">57</xref>]). Inosine can activate A<sub>3</sub>AR on mouse mast cells [<xref ref-type="bibr" rid="pbio.3000161.ref043">43</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref058">58</xref>]. Inosine has also been reported to be an agonist at A<sub>1</sub>AR [<xref ref-type="bibr" rid="pbio.3000161.ref059">59</xref>], A<sub>2A</sub>AR [<xref ref-type="bibr" rid="pbio.3000161.ref060">60</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref061">61</xref>], and A<sub>2B</sub>AR [<xref ref-type="bibr" rid="pbio.3000161.ref062">62</xref>]. Our QKO and follow-up experiments demonstrate that inosine-induced hypothermia is due to A<sub>3</sub>AR agonism.</p>
<p>Caffeine is an AR antagonist [<xref ref-type="bibr" rid="pbio.3000161.ref040">40</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref041">41</xref>]. At higher concentrations, it inhibits phosphodiesterases [<xref ref-type="bibr" rid="pbio.3000161.ref063">63</xref>], γ-aminobutyric acid A (GABA<sub>A</sub>) receptors [<xref ref-type="bibr" rid="pbio.3000161.ref063">63</xref>], and glycine receptors [<xref ref-type="bibr" rid="pbio.3000161.ref064">64</xref>] and activates ryanodine receptors [<xref ref-type="bibr" rid="pbio.3000161.ref065">65</xref>]. We examined a 30 mg/kg dose, which approximates the human plasma exposure of 2–3 cups of coffee [<xref ref-type="bibr" rid="pbio.3000161.ref066">66</xref>]. Our data confirm that the effects of caffeine (30 mg/kg) to increase Tb and activity are mediated by ARs, likely A<sub>2A</sub>AR [<xref ref-type="bibr" rid="pbio.3000161.ref042">42</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref067">67</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref068">68</xref>].</p>
<p>The protective effects of guanosine in the central nervous system (CNS) have been studied, revealing apparent adenosine-dependent and -independent effects, but a guanosine receptor has not been identified [<xref ref-type="bibr" rid="pbio.3000161.ref069">69</xref>–<xref ref-type="bibr" rid="pbio.3000161.ref071">71</xref>]. While more mechanistic studies of guanosine’s effects are warranted, we were unable to explore this with QKO mice, because a high, solubility-limited dose of guanosine (60 mg/kg, i.p.) [<xref ref-type="bibr" rid="pbio.3000161.ref070">70</xref>] failed to lower Tb in wild-type mice.</p>
</sec>
<sec id="sec016">
<title>Mechanism of uridine-induced hypothermia</title>
<p>We were surprised by the QKO results demonstrating that uridine-induced hypothermia requires ARs. Uridine (at doses reaching ≥10 mM in plasma) causes hypothermia in mice and rats [<xref ref-type="bibr" rid="pbio.3000161.ref048">48</xref>]. A recent study found that physiological plasma uridine levels decreased with feeding and increased with fasting (albeit in a much lower range, 4–10 μM) and suggested that uridine was linked to the reduction in Tb that occurs during fasting [<xref ref-type="bibr" rid="pbio.3000161.ref047">47</xref>]. The result that uridine-induced hypothermia is absent in QKO mice caused us to investigate further. Uridine itself does not bind to ARs [<xref ref-type="bibr" rid="pbio.3000161.ref072">72</xref>], is not a substrate for adenosine kinase [<xref ref-type="bibr" rid="pbio.3000161.ref073">73</xref>], and does not block adenosine deaminase [<xref ref-type="bibr" rid="pbio.3000161.ref074">74</xref>]. However, uridine is a substrate for transport by ENT1 and a competitive inhibitor of adenosine transport by ENT1 [<xref ref-type="bibr" rid="pbio.3000161.ref045">45</xref>, <xref ref-type="bibr" rid="pbio.3000161.ref046">46</xref>], and we showed that uridine mimicked the effects of the selective ENT1 inhibitor, NBMPR. Thus, we propose that the pharmacologic effects of uridine are due at least in part to inhibition of ENT1, preventing adenosine uptake into cells. The increased extracellular adenosine activates multiple ARs (mast cell A<sub>3</sub>AR and other ARs). This may explain the sleep-promoting and anticonvulsant effects of uridine (reviewed in [<xref ref-type="bibr" rid="pbio.3000161.ref075">75</xref>]). It seems likely that this AR-dependent mechanism for Tb regulation with large exogenous uridine doses does not explain Tb effects of changes of uridine levels in the physiologic range.</p>
</sec>
<sec id="sec017">
<title>AR-independent effects of adenosine</title>
<p>The QKO mice described here are a valuable research tool to study AR-independent effects of adenosine. Adenosine is an obligatory product of S-adenosylmethionine (SAM)–dependent transmethylation reactions, which include DNA methylation and histone methylation. Through mass action, adenosine provides negative feedback control for transmethylation—low levels of adenosine drive DNA methylation, whereas high levels of adenosine block DNA methylation [<xref ref-type="bibr" rid="pbio.3000161.ref076">76</xref>]. The QKO mice would be an ideal investigative tool to study the epigenetic mechanisms of adenosine in the absence of potentially confounding ARs.</p>
</sec>
<sec id="sec018">
<title>Limitations</title>
<p>We monitored growth and metabolic parameters, Tb, activity, and cardiovascular end points. Other assays might expose additional differences in the QKO mice. While the mice have a mixed genetic background, both QKO and control mice were bred using a scheme to minimize founder/inbreeding effects. Lastly, mice with germline AR deletion may have undergone adaptive changes during development, masking deficits due to loss of ARs [<xref ref-type="bibr" rid="pbio.3000161.ref077">77</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref078">78</xref>]. Use of conditional AR alleles with deletion in adulthood would avoid this potential confound.</p>
</sec>
<sec id="sec019">
<title>Implications</title>
<p>We have demonstrated that the physiology elicited by adenosine, uridine, inosine, caffeine, and (partially) AMP requires ARs. It is notable that the QKO mouse phenotype replicates that of individual AR knockout mice, without evidence for synergy, suggesting that the actions of the four ARs are generally complementary. The phenotype of the QKO mice supports the hypothesis that extracellular adenosine has less of a contribution to baseline physiology and is likely more important for its roles as a signal of stress, damage, and/or danger.</p>
</sec>
</sec>
<sec id="sec020" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="sec021">
<title>Ethics statement</title>
<p>Studies were approved by the Animal Care and Use Committee of National Institute of Diabetes and Digestive and Kidney Diseases, animal protocol K016-DEOB-17. Mice were anesthetized with isoflurane or ketamine and xylazine. Euthanasia of anesthetized mice was performed by exsanguination via retro-orbital bleeding followed by cervical dislocation.</p>
</sec>
<sec id="sec022">
<title>Mice</title>
<p>Male C57BL/6J and <italic>Kit</italic><sup><italic>W−sh/W−sh</italic></sup> (JAX 012861) mice were obtained from the Jackson Laboratory. <italic>Adora1</italic><sup><italic>−</italic>/<italic>−</italic></sup> [<xref ref-type="bibr" rid="pbio.3000161.ref024">24</xref>], <italic>Adora2b</italic><sup><italic>−</italic>/<italic>−</italic></sup> [<xref ref-type="bibr" rid="pbio.3000161.ref026">26</xref>] (JAX 022499), and <italic>Adora3</italic><sup><italic>−</italic>/<italic>−</italic></sup> [<xref ref-type="bibr" rid="pbio.3000161.ref018">18</xref>] mice were on a C57BL/6J genetic background. The <italic>Adora2a</italic><sup><italic>−</italic>/<italic>−</italic></sup> mice [<xref ref-type="bibr" rid="pbio.3000161.ref025">25</xref>] (JAX 010685) were on a mixed background. Mice were genotyped as described (<xref ref-type="supplementary-material" rid="pbio.3000161.s003">S3 Fig</xref>) [<xref ref-type="bibr" rid="pbio.3000161.ref015">15</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref021">21</xref>]. Mice were singly housed at about 22°C with a 12:12-hour light–dark cycle. Chow (NIH-07, Envigo, Madison, WI) or high-fat diet (D12492, 60% kcal fat, 5.24 metabolizable kcal/g; Research Diets) and water were available ad libitum. Mice were studied ≥7 days after any operation or prior treatment. Reuse of mice tends to reduce physical activity levels, presumably due to acclimation. No specific effort was made to acclimate mice to handling in individual experiments.</p>
<p>To generate QKO mice, mice heterozygous at all four loci (<italic>Adora1</italic><sup>+/<italic>−</italic></sup>;<italic>Adora2a</italic><sup>+/<italic>−</italic></sup>;<italic>Adora2b</italic><sup>+/<italic>−</italic></sup>;<italic>Adora3</italic><sup>+/<italic>−</italic></sup>) were crossed. Of 334 progeny (310 successfully genotyped at all four loci), the <italic>Adora2a</italic>, <italic>Adora2b</italic>, and <italic>Adora3</italic> alleles were transmitted in the expected mendelian ratios. The <italic>Adora1</italic><sup><italic>−</italic></sup> allele was slightly underrepresented (+/+:+/−:−/−, observed 109:146:65 versus expected 80:160:80, χ<sup>2</sup> <italic>P</italic> = 0.0007), as observed previously [<xref ref-type="bibr" rid="pbio.3000161.ref027">27</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref028">28</xref>]. There was no pairwise interaction of the <italic>Adora1</italic><sup><italic>−</italic>/<italic>−</italic></sup> genotype with genotype at the other three loci (the mice with <italic>Adora1</italic><sup><italic>−</italic>/<italic>−</italic></sup> genotype had the expected 1:2:1 +/+:+/−:−/− ratios for each of the <italic>Adora2a</italic>, <italic>Adora2b</italic>, and <italic>Adora3</italic> loci). The QKO mice studied were the second- or third-generation progeny from the quad heterozygote intercross. Controls were +/+ or +/− at the four AR loci and are also second- or third-generation progeny of quad heterozygote intercross.</p>
</sec>
<sec id="sec023">
<title>Compounds</title>
<p>Compounds (source; vehicle) were obtained as follows: 5′-AMP (Sigma A1752; saline), adenosine (Sigma; 10% DMSO in saline), uridine (Sigma 1707114; saline), A134974 (Sigma A2846; saline), caffeine (Sigma; saline), dipyridamole (Sigma; 10% DMSO in saline), EHNA (erythro-9-(2-Hydroxy-3-nonyl)adenine hydrochloride, Tocris 1261; 10% DMSO; 10 mg/kg dose chosen to avoid phosphodiesterase inhibition [<xref ref-type="bibr" rid="pbio.3000161.ref079">79</xref>]), inosine (Sigma I4125; saline; dose based on [<xref ref-type="bibr" rid="pbio.3000161.ref080">80</xref>]), NBMPR (6-S-[(4-Nitrophenyl)methyl]-6-thioinosine, Tocris 2924; warm 10% DMSO in saline), and LPS (Sigma L6511; saline).</p>
</sec>
<sec id="sec024">
<title>In vivo physiology</title>
<p>Tb and activity were continuously measured by telemetry, using i.p. G2 E-mitters, ER4000 energizer/receivers, and VitalView software (Starr Life Sciences, Oakmont, PA), with data collected each minute [<xref ref-type="bibr" rid="pbio.3000161.ref081">81</xref>]. Average Tb over 0–60 minutes and nadir Tb during 0–90 minutes after drug injection were used to quantitate hypothermic effects. Average activity over 0–60 minutes captures the reduced activity that accompanies hypothermia. Total minutes &lt;34°C, a better measure of prolonged hypothermia, did not add useful information. Inhibitors were dosed 20–25 minutes before agonists.</p>
<p>Continuous ambulatory intra-arterial blood pressure, heart rate, physical activity, and Tb were measured with radio transmitters (HD-X11, Data Sciences International, St Paul, MN) implanted under ketamine and xylazine anesthesia in the carotid artery as described [<xref ref-type="bibr" rid="pbio.3000161.ref082">82</xref>]. Data were sampled at 1,000 Hz using a PhysioTel RPC-1 receiver and Ponemah v6.30 (Data Sciences International) software, with 1-minute averages used for analysis. The pulse pressure is the difference between the systolic and diastolic blood pressure, expressed as a percentage of the systolic pressure.</p>
<p>The following assays were used: β-hydroxybutyrate (colorimetric, #K632, BioVision), corticosterone (RIA, #07120102, MP Biomedicals), T3 (ELISA, #T3043T-100, Calbiotech) and T4 (ELISA, #T4044T-100, Calbiotech). Cytokines were measured in plasma obtained 2 hours after dosing [<xref ref-type="bibr" rid="pbio.3000161.ref083">83</xref>] LPS (250 μg/kg, i.p.) or vehicle using the Mouse Magnetic Luminex Assay Kit (LXSAMSM, R&amp;D Systems), performed by the NHLBI Flow Cytometry Core.</p>
<p>Plasma adenosine and uridine measurement: 30 minutes after dosing with uridine or vehicle, C57BL/6J mice were anesthetized with isoflurane, and blood was drawn retro-orbitally into an equal volume of ice-cold stop solution (5 μM EHNA, 200 μM dipyridamole, 4 mM EDTA in saline) to prevent generation or loss of adenosine [<xref ref-type="bibr" rid="pbio.3000161.ref084">84</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref085">85</xref>]. Samples were centrifuged (4°C, 13,000 rpm, 3 minutes), 50 μL of plasma was pipetted into 200 μL of methanol containing internal standards (<sup>13</sup>C<sub>9</sub>,<sup>15</sup>N<sub>2</sub>-uridine and <sup>13</sup>C<sub>5</sub>-adenosine, Cambridge Isotopes), vortexed (5 minutes), centrifuged (4°C, 14,000 rpm, 10 minutes), and the supernatant was dried at room temperature under nitrogen and resuspended in 125 μL H<sub>2</sub>O. Samples were analyzed by UPLC-MS/MS using a Vanquish UPLC (Thermo Scientific) and Altis LC-Triple quadrupole mass spectrometer (Thermo Scientific) with heated electrospray ionization (HESI-II, Thermo Scientific) in positive ion mode (3,500 V). Injection volume was 1 μL (autosampler at 5°C), using a Waters Cortecs C18 + 2.7 μm, 2.1 × 100 mm UPLC column (35°C) at 350 μL/minute with solvent A (0.1% formic acid in H<sub>2</sub>O) and solvent B (0.1% formic acid in methanol). Initially, 99% solvent A for 0.25 minutes, linearly changing to 10% A at 2.15 minutes, remaining at 10% A until 3 minutes, linearly changing to 99% A by 3.5 minutes, and stabilizing for 3 minutes. Transitions quantitated were (m/z): adenosine, 268→119 and 268→136; <sup>13</sup>C<sub>5</sub>-adenosine 273→119 and 273→136; uridine, 245→96 and 245→113; and <sup>13</sup>C<sub>9</sub>,<sup>15</sup>N<sub>2</sub>-uridine, 256→101 and 256→119. Adenosine was calibrated (<italic>R</italic><sup>2</sup> ≥ 0.999) from 1.0 to 2,500 ng/mL and uridine from 0.25 to 750 μg/mL in the original samples. Literature plasma adenosine levels are 100 to 1,000 nM in human [<xref ref-type="bibr" rid="pbio.3000161.ref054">54</xref>] and 145 to 6,100 nM in mouse [<xref ref-type="bibr" rid="pbio.3000161.ref038">38</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref086">86</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref087">87</xref>].</p>
<p>Metabolic phenotyping, including glucose and insulin tolerance tests and hormone and metabolite profiles, were performed as previously described [<xref ref-type="bibr" rid="pbio.3000161.ref088">88</xref>].</p>
<p>Complete blood count with differential and serum chemistry tests were performed by the Department of Laboratory Medicine, NIH Clinical Center.</p>
<p>Statistical analyses were all two tailed, performed using Prism, and are detailed in <xref ref-type="supplementary-material" rid="pbio.3000161.s020">S6 Table</xref>.</p>
</sec>
</sec>
<sec id="sec025">
<title>Supporting information</title>
<supplementary-material id="pbio.3000161.s001" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.s001" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>Phenotype of chow-fed female QKO and control mice, group housed.</title>
<p>QKO mice showed reduced body weight due to decreased lean mass at younger age (8–19 weeks, A-C), reduced fed glucose, improved glucose tolerance without changes in insulin tolerance test and insulin levels (D-J). QKO mice also had lower serum FFA, TG, and cholesterol, as well as IGF-1 levels (K-P). At euthanasia (37 weeks), there was no difference in body weight, body length, and organ weights (Q-T). FFA, free fatty acid; IGF-1, insulin-like growth factor 1; QKO, quad knockout; TG, triglyceride.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000161.s002" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.s002" xlink:type="simple">
<label>S2 Fig</label>
<caption>
<title>Phenotype of male QKO and control mice.</title>
<p>Mice were singly housed, fed either on chow or a HFD starting at 8 weeks of age. QKO mice had lower body weight when young (8–16 weeks) due to reduced lean mass on both chow and HFD (A-C). Chow-fed QKO mice had improved glucose tolerance without changes in fed glucose and insulin levels (D-H), reduced levels of FFA, cholesterol, and IGF-1 (P-U). Spleen weight was increased in HFD-fed mice (O, rightmost panel) and trending increase in chow-fed mice (N, rightmost panel). HFD-fed QKO mice showed no clear changes compared with controls (I-M, O first three panels, V-AC). Numerical data are in Supporting information. FFA, free fatty acid; HFD, high-fat diet; QKO, quad knockout.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000161.s003" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.s003" xlink:type="simple">
<label>S3 Fig</label>
<caption>
<title>Genotyping of Adora1, Adora2a, Adora2b, and Adora3 alleles.</title>
<p>Protocols are in [<xref ref-type="bibr" rid="pbio.3000161.ref015">15</xref>,<xref ref-type="bibr" rid="pbio.3000161.ref017">17</xref>] and references therein. The spurious band in <italic>Adora2a</italic> genotyping can be eliminated by using a hot start protocol.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000161.s004" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.s004" xlink:type="simple">
<label>S1 Data</label>
<caption>
<title>Underlying data for <xref ref-type="fig" rid="pbio.3000161.g001">Fig 1</xref> in GraphPad Prism v7.</title>
<p>(PZFX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000161.s005" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.s005" xlink:type="simple">
<label>S2 Data</label>
<caption>
<title>Underlying data for <xref ref-type="fig" rid="pbio.3000161.g002">Fig 2</xref> in GraphPad Prism v7.</title>
<p>(PZFX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000161.s006" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.s006" xlink:type="simple">
<label>S3 Data</label>
<caption>
<title>Underlying data for <xref ref-type="fig" rid="pbio.3000161.g003">Fig 3</xref> in GraphPad Prism v7.</title>
<p>(PZFX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000161.s007" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.s007" xlink:type="simple">
<label>S4 Data</label>
<caption>
<title>Underlying data for <xref ref-type="fig" rid="pbio.3000161.g004">Fig 4</xref> in GraphPad Prism v7.</title>
<p>(PZFX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000161.s008" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.s008" xlink:type="simple">
<label>S5 Data</label>
<caption>
<title>Underlying data for <xref ref-type="fig" rid="pbio.3000161.g005">Fig 5</xref> in GraphPad Prism v7.</title>
<p>(PZFX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000161.s009" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.s009" xlink:type="simple">
<label>S6 Data</label>
<caption>
<title>Underlying data for <xref ref-type="fig" rid="pbio.3000161.g006">Fig 6</xref> in GraphPad Prism v7.</title>
<p>(PZFX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000161.s010" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.s010" xlink:type="simple">
<label>S7 Data</label>
<caption>
<title>Underlying data for <xref ref-type="fig" rid="pbio.3000161.g007">Fig 7</xref> in GraphPad Prism v7.</title>
<p>(PZFX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000161.s011" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.s011" xlink:type="simple">
<label>S8 Data</label>
<caption>
<title>Underlying data for <xref ref-type="fig" rid="pbio.3000161.g008">Fig 8</xref> in GraphPad Prism v7.</title>
<p>(PZFX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000161.s012" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.s012" xlink:type="simple">
<label>S9 Data</label>
<caption>
<title>Underlying data for <xref ref-type="fig" rid="pbio.3000161.g009">Fig 9</xref> in GraphPad Prism v7.</title>
<p>(PZFX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000161.s013" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.s013" xlink:type="simple">
<label>S10 Data</label>
<caption>
<title>Underlying data for <xref ref-type="supplementary-material" rid="pbio.3000161.s001">S1 Fig</xref> in GraphPad Prism v7.</title>
<p>(PZFX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000161.s014" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.s014" xlink:type="simple">
<label>S11 Data</label>
<caption>
<title>Underlying data for <xref ref-type="supplementary-material" rid="pbio.3000161.s002">S2 Fig</xref> in GraphPad Prism v7.</title>
<p>(PZFX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000161.s015" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.s015" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>Hematology in control and QKO mice.</title>
<p>QKO, quad knockout.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000161.s016" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.s016" xlink:type="simple">
<label>S2 Table</label>
<caption>
<title>Serum chemistries in control and QKO mice.</title>
<p>QKO, quad knockout.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000161.s017" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.s017" xlink:type="simple">
<label>S3 Table</label>
<caption>
<title>Related to <xref ref-type="table" rid="pbio.3000161.t001">Table 1</xref>.</title>
<p>Phenotype of older male mice.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000161.s018" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.s018" xlink:type="simple">
<label>S4 Table</label>
<caption>
<title>Adipose tissue mRNA levels.</title>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000161.s019" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.s019" xlink:type="simple">
<label>S5 Table</label>
<caption>
<title>Cytokine response to LPS in QKO and control (WT) mice.</title>
<p>LPS, lipopolysaccharide; QKO, quad knockout; WT, wild-type.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000161.s020" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000161.s020" xlink:type="simple">
<label>S6 Table</label>
<caption>
<title>Statistical results in excel.</title>
<p>(XLSX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We thank Alice Franks and Yinyan Ma for superb support, Audrey Noguchi (NHLBI Phenotyping Core) for cardiovascular telemeter implantation, Peter Walter and Hongyi Cai (NIDDK Mass Spec Core) for assay of plasma adenosine and uridine, the NHLBI Flow Cytometry Core for cytokine assays, and Michael Eckhaus (Division of Veterinary Resources) for the necropsy analysis.</p>
</ack>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item><term>AMP</term>
<def><p>adenosine 5′-monophosphate</p></def>
</def-item>
<def-item><term>AMPK</term>
<def><p>adenosine monophosphate–activated protein kinase</p></def>
</def-item>
<def-item><term>AR</term>
<def><p>adenosine receptor</p></def>
</def-item>
<def-item><term>BAT</term>
<def><p>brown adipose tissue</p></def>
</def-item>
<def-item><term>bpm</term>
<def><p>beats per minute</p></def>
</def-item>
<def-item><term>CNS</term>
<def><p>central nervous system</p></def>
</def-item>
<def-item><term>ENT1</term>
<def><p>equilibrative nucleoside transporter 1</p></def>
</def-item>
<def-item><term>IGF-1</term>
<def><p>insulin-like growth factor-1</p></def>
</def-item>
<def-item><term>i.p.</term>
<def><p>intraperitoneal</p></def>
</def-item>
<def-item><term>LPS</term>
<def><p>lipopolysaccharide</p></def>
</def-item>
<def-item><term>MAP</term>
<def><p>mean arterial blood pressure</p></def>
</def-item>
<def-item><term>NBMPR</term>
<def><p>6-S-[(4-Nitrophenyl)methyl]-6-thioinosine</p></def>
</def-item>
<def-item><term>QKO</term>
<def><p>quad knockout</p></def>
</def-item>
<def-item><term>SAM</term>
<def><p>S-adenosylmethionine</p></def>
</def-item>
<def-item><term>Tb</term>
<def><p>core body temperature</p></def>
</def-item>
<def-item><term>T3</term>
<def><p>triiodothyronine</p></def>
</def-item>
<def-item><term>T4</term>
<def><p>thyroxine</p></def>
</def-item>
<def-item><term>WAT</term>
<def><p>white adipose tissue</p></def>
</def-item>
</def-list>
</glossary>
<ref-list>
<title>References</title>
<ref id="pbio.3000161.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fredholm</surname> <given-names>BB</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Masino</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Vaugeois</surname> <given-names>JM</given-names></name>. <article-title>Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs</article-title>. <source>Annu Rev Pharmacol Toxicol</source>. <year>2005</year>;<volume>45</volume>:<fpage>385</fpage>–<lpage>412</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1146/annurev.pharmtox.45.120403.095731" xlink:type="simple">10.1146/annurev.pharmtox.45.120403.095731</ext-link></comment> <object-id pub-id-type="pmid">15822182</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fredholm</surname> <given-names>BB</given-names></name>. <article-title>Adenosine—a physiological or pathophysiological agent?</article-title> <source>J Mol Med</source> (Berl). <year>2014</year>;<volume>92</volume>(<issue>3</issue>):<fpage>201</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00109-013-1101-6" xlink:type="simple">10.1007/s00109-013-1101-6</ext-link></comment> <object-id pub-id-type="pmid">24362516</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Antonioli</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Blandizzi</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Csoka</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Pacher</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Hasko</surname> <given-names>G</given-names></name>. <article-title>Adenosine signalling in diabetes mellitus-pathophysiology and therapeutic considerations</article-title>. <source>Nat Rev Endocrinol</source>. <year>2015</year>;<volume>11</volume>(<issue>4</issue>):<fpage>228</fpage>–<lpage>41</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrendo.2015.10" xlink:type="simple">10.1038/nrendo.2015.10</ext-link></comment> <object-id pub-id-type="pmid">25687993</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Al Jaroudi</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Iskandrian</surname> <given-names>AE</given-names></name>. <article-title>Regadenoson: a new myocardial stress agent</article-title>. <source>J Am Coll Cardiol</source>. <year>2009</year>;<volume>54</volume>(<issue>13</issue>):<fpage>1123</fpage>–<lpage>30</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jacc.2009.04.089" xlink:type="simple">10.1016/j.jacc.2009.04.089</ext-link></comment> <object-id pub-id-type="pmid">19761931</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nazario</surname> <given-names>LR</given-names></name>, <name name-style="western"><surname>da Silva</surname> <given-names>RS</given-names></name>, <name name-style="western"><surname>Bonan</surname> <given-names>CD</given-names></name>. <article-title>Targeting Adenosine Signaling in Parkinson's Disease: From Pharmacological to Non-pharmacological Approaches</article-title>. <source>Front Neurosci</source>. <year>2017</year>;<volume>11</volume>:<fpage>658</fpage>. Epub 2017/12/09. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnins.2017.00658" xlink:type="simple">10.3389/fnins.2017.00658</ext-link></comment> <object-id pub-id-type="pmid">29217998</object-id>; PubMed Central PMCID: PMCPMC5703841.</mixed-citation></ref>
<ref id="pbio.3000161.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Eltzschig</surname> <given-names>HK</given-names></name>, <name name-style="western"><surname>Fredholm</surname> <given-names>BB</given-names></name>. <article-title>Adenosine receptors as drug targets—what are the challenges?</article-title> <source>Nat Rev Drug Discov</source>. <year>2013</year>;<volume>12</volume>(<issue>4</issue>):<fpage>265</fpage>–<lpage>86</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrd3955" xlink:type="simple">10.1038/nrd3955</ext-link></comment> <object-id pub-id-type="pmid">23535933</object-id>; PubMed Central PMCID: PMC3930074.</mixed-citation></ref>
<ref id="pbio.3000161.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Borea</surname> <given-names>PA</given-names></name>, <name name-style="western"><surname>Gessi</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Merighi</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Vincenzi</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Varani</surname> <given-names>K</given-names></name>. <article-title>Pharmacology of Adenosine Receptors: The State of the Art</article-title>. <source>Physiol Rev</source>. <year>2018</year>;<volume>98</volume>(<issue>3</issue>):<fpage>1591</fpage>–<lpage>625</lpage>. Epub 2018/06/01. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/physrev.00049.2017" xlink:type="simple">10.1152/physrev.00049.2017</ext-link></comment> <object-id pub-id-type="pmid">29848236</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bennet</surname> <given-names>DW</given-names></name>, <name name-style="western"><surname>Drury</surname> <given-names>AN</given-names></name>. <article-title>Further observations relating to the physiological activity of adenine compounds</article-title>. <source>J Physiol</source>. <year>1931</year>;<volume>72</volume>(<issue>3</issue>):<fpage>288</fpage>–<lpage>320</lpage>. <object-id pub-id-type="pmid">16994210</object-id>; PubMed Central PMCID: PMC1403115.</mixed-citation></ref>
<ref id="pbio.3000161.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Anderson</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Sheehan</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Strong</surname> <given-names>P</given-names></name>. <article-title>Characterization of the adenosine receptors mediating hypothermia in the conscious mouse</article-title>. <source>Br J Pharmacol</source>. <year>1994</year>;<volume>113</volume>(<issue>4</issue>):<fpage>1386</fpage>–<lpage>90</lpage>. Epub 1994/12/01. <object-id pub-id-type="pmid">7889296</object-id>; PubMed Central PMCID: PMC1510495.</mixed-citation></ref>
<ref id="pbio.3000161.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Johansson</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Halldner</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Dunwiddie</surname> <given-names>TV</given-names></name>, <name name-style="western"><surname>Masino</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Poelchen</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Gimenez-Llort</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2001</year>;<volume>98</volume>(<issue>16</issue>):<fpage>9407</fpage>–<lpage>12</lpage>. Epub 2001/07/27. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.161292398" xlink:type="simple">10.1073/pnas.161292398</ext-link></comment> 161292398 [pii]. <object-id pub-id-type="pmid">11470917</object-id>; PubMed Central PMCID: PMC55434.</mixed-citation></ref>
<ref id="pbio.3000161.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tupone</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Madden</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Morrison</surname> <given-names>SF</given-names></name>. <article-title>Central activation of the A1 adenosine receptor (A1AR) induces a hypothermic, torpor-like state in the rat</article-title>. <source>J Neurosci</source>. <year>2013</year>;<volume>33</volume>(<issue>36</issue>):<fpage>14512</fpage>–<lpage>25</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1523/JNEUROSCI.1980-13.2013" xlink:type="simple">10.1523/JNEUROSCI.1980-13.2013</ext-link></comment> <object-id pub-id-type="pmid">24005302</object-id>; PubMed Central PMCID: PMCPMC3761054.</mixed-citation></ref>
<ref id="pbio.3000161.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ticho</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>Radulovacki</surname> <given-names>M</given-names></name>. <article-title>Role of adenosine in sleep and temperature regulation in the preoptic area of rats</article-title>. <source>Pharmacol Biochem Behav</source>. <year>1991</year>;<volume>40</volume>(<issue>1</issue>):<fpage>33</fpage>–<lpage>40</lpage>. Epub 1991/09/01. <object-id pub-id-type="pmid">1780343</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shintani</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Tamura</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Monden</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Shiomi</surname> <given-names>H</given-names></name>. <article-title>Characterization of N(6)-cyclohexyladenosine-induced hypothermia in Syrian hamsters</article-title>. <source>J Pharmacol Sci</source>. <year>2005</year>;<volume>97</volume>(<issue>3</issue>):<fpage>451</fpage>–<lpage>4</lpage>. <object-id pub-id-type="pmid">15764835</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Silvani</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Cerri</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Zoccoli</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Swoap</surname> <given-names>SJ</given-names></name>. <article-title>Is Adenosine Action Common Ground for NREM Sleep, Torpor, and Other Hypometabolic States?</article-title> <source>Physiology</source> (Bethesda). <year>2018</year>;<volume>33</volume>(<issue>3</issue>):<fpage>182</fpage>–<lpage>96</lpage>. Epub 2018/04/05. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/physiol.00007.2018" xlink:type="simple">10.1152/physiol.00007.2018</ext-link></comment> <object-id pub-id-type="pmid">29616880</object-id>; PubMed Central PMCID: PMCPMC5966658.</mixed-citation></ref>
<ref id="pbio.3000161.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Carlin</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Jain</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Gizewski</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Wan</surname> <given-names>TC</given-names></name>, <name name-style="western"><surname>Tosh</surname> <given-names>DK</given-names></name>, <name name-style="western"><surname>Xiao</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Hypothermia in mouse is caused by adenosine A1 and A3 receptor agonists and AMP via three distinct mechanisms</article-title>. <source>Neuropharmacology</source>. <year>2017</year>;<volume>114</volume>:<fpage>101</fpage>–<lpage>13</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.neuropharm.2016.11.026" xlink:type="simple">10.1016/j.neuropharm.2016.11.026</ext-link></comment> <object-id pub-id-type="pmid">27914963</object-id>; PubMed Central PMCID: PMCPMC5183552.</mixed-citation></ref>
<ref id="pbio.3000161.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Auchampach</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Rizvi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Qiu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Tang</surname> <given-names>XL</given-names></name>, <name name-style="western"><surname>Maldonado</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Teschner</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Selective activation of A3 adenosine receptors with N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits</article-title>. <source>Circ Res</source>. <year>1997</year>;<volume>80</volume>(<issue>6</issue>):<fpage>800</fpage>–<lpage>9</lpage>. <object-id pub-id-type="pmid">9168782</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fozard</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Pfannkuche</surname> <given-names>HJ</given-names></name>, <name name-style="western"><surname>Schuurman</surname> <given-names>HJ</given-names></name>. <article-title>Mast cell degranulation following adenosine A3 receptor activation in rats</article-title>. <source>Eur J Pharmacol</source>. <year>1996</year>;<volume>298</volume>(<issue>3</issue>):<fpage>293</fpage>–<lpage>7</lpage>. <object-id pub-id-type="pmid">8846829</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Salvatore</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Tilley</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Latour</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Fletcher</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Koller</surname> <given-names>BH</given-names></name>, <name name-style="western"><surname>Jacobson</surname> <given-names>MA</given-names></name>. <article-title>Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells</article-title>. <source>J Biol Chem</source>. <year>2000</year>;<volume>275</volume>(<issue>6</issue>):<fpage>4429</fpage>–<lpage>34</lpage>. Epub 2000/02/08. <object-id pub-id-type="pmid">10660615</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Carlin</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Tosh</surname> <given-names>DK</given-names></name>, <name name-style="western"><surname>Xiao</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Pinol</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Salvemini</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Peripheral Adenosine A3 Receptor Activation Causes Regulated Hypothermia in Mice That Is Dependent on Central Histamine H1 Receptors</article-title>. <source>J Pharmacol Exp Ther</source>. <year>2016</year>;<volume>356</volume>(<issue>2</issue>):<fpage>474</fpage>–<lpage>82</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1124/jpet.115.229872" xlink:type="simple">10.1124/jpet.115.229872</ext-link></comment> <object-id pub-id-type="pmid">26606937</object-id>; PubMed Central PMCID: PMCPMC4746492.</mixed-citation></ref>
<ref id="pbio.3000161.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jain</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Panyutin</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Xiao</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Pinol</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Pundir</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Melanotan II causes hypothermia in mice by activation of mast cells and stimulation of histamine 1 receptors</article-title>. <source>Am J Physiol Endocrinol Metab</source>. <year>2018</year>;<volume>315</volume>(<issue>3</issue>):<fpage>E357</fpage>–<lpage>E66</lpage>. Epub 2018/05/31. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpendo.00024.2018" xlink:type="simple">10.1152/ajpendo.00024.2018</ext-link></comment> <object-id pub-id-type="pmid">29812984</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Carlin</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Jain</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Duroux</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Suresh</surname> <given-names>RR</given-names></name>, <name name-style="western"><surname>Xiao</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Auchampach</surname> <given-names>JA</given-names></name>, <etal>et al</etal>. <article-title>Activation of adenosine A2A or A2B receptors causes hypothermia in mice</article-title>. <source>Neuropharmacology</source>. <year>2018</year>;<volume>139</volume>:<fpage>268</fpage>–<lpage>78</lpage>. Epub 2018/03/20. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.neuropharm.2018.02.035" xlink:type="simple">10.1016/j.neuropharm.2018.02.035</ext-link></comment> <object-id pub-id-type="pmid">29548686</object-id>; PubMed Central PMCID: PMCPMC6067974.</mixed-citation></ref>
<ref id="pbio.3000161.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lin</surname> <given-names>SC</given-names></name>, <name name-style="western"><surname>Hardie</surname> <given-names>DG</given-names></name>. <article-title>AMPK: Sensing Glucose as well as Cellular Energy Status</article-title>. <source>Cell Metab</source>. <year>2018</year>;<volume>27</volume>(<issue>2</issue>):<fpage>299</fpage>–<lpage>313</lpage>. Epub 2017/11/21. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cmet.2017.10.009" xlink:type="simple">10.1016/j.cmet.2017.10.009</ext-link></comment> <object-id pub-id-type="pmid">29153408</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Melvin</surname> <given-names>RG</given-names></name>, <name name-style="western"><surname>Andrews</surname> <given-names>MT</given-names></name>. <article-title>Torpor induction in mammals: recent discoveries fueling new ideas</article-title>. <source>Trends Endocrinol Metab</source>. <year>2009</year>;<volume>20</volume>(<issue>10</issue>):<fpage>490</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.tem.2009.09.005" xlink:type="simple">10.1016/j.tem.2009.09.005</ext-link></comment> <object-id pub-id-type="pmid">19864159</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sun</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Samuelson</surname> <given-names>LC</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Paliege</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Saunders</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2001</year>;<volume>98</volume>(<issue>17</issue>):<fpage>9983</fpage>–<lpage>8</lpage>. Epub 2001/08/16. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.171317998" xlink:type="simple">10.1073/pnas.171317998</ext-link></comment> 98/17/9983 [pii]. <object-id pub-id-type="pmid">11504952</object-id>; PubMed Central PMCID: PMC55564.</mixed-citation></ref>
<ref id="pbio.3000161.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Ma</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Moratalla</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Standaert</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice</article-title>. <source>J Neurosci</source>. <year>1999</year>;<volume>19</volume>(<issue>21</issue>):<fpage>9192</fpage>–<lpage>200</lpage>. <object-id pub-id-type="pmid">10531422</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hua</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Kovarova</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Chason</surname> <given-names>KD</given-names></name>, <name name-style="western"><surname>Nguyen</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Koller</surname> <given-names>BH</given-names></name>, <name name-style="western"><surname>Tilley</surname> <given-names>SL</given-names></name>. <article-title>Enhanced mast cell activation in mice deficient in the A2b adenosine receptor</article-title>. <source>J Exp Med</source>. <year>2007</year>;<volume>204</volume>(<issue>1</issue>):<fpage>117</fpage>–<lpage>28</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1084/jem.20061372" xlink:type="simple">10.1084/jem.20061372</ext-link></comment> <object-id pub-id-type="pmid">17200408</object-id>; PubMed Central PMCID: PMCPMC2118413.</mixed-citation></ref>
<ref id="pbio.3000161.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Minelli</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Liguori</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Bellazza</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Mannucci</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Johansson</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Fredholm</surname> <given-names>BB</given-names></name>. <article-title>Involvement of A1 adenosine receptors in the acquisition of fertilizing capacity</article-title>. <source>J Androl</source>. <year>2004</year>;<volume>25</volume>(<issue>2</issue>):<fpage>286</fpage>–<lpage>92</lpage>. <object-id pub-id-type="pmid">14760015</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gimenez-Llort</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Fernandez-Teruel</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Escorihuela</surname> <given-names>RM</given-names></name>, <name name-style="western"><surname>Fredholm</surname> <given-names>BB</given-names></name>, <name name-style="western"><surname>Tobena</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Pekny</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Mice lacking the adenosine A1 receptor are anxious and aggressive, but are normal learners with reduced muscle strength and survival rate</article-title>. <source>Eur J Neurosci</source>. <year>2002</year>;<volume>16</volume>(<issue>3</issue>):<fpage>547</fpage>–<lpage>50</lpage>. <object-id pub-id-type="pmid">12193199</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rudaya</surname> <given-names>AY</given-names></name>, <name name-style="western"><surname>Steiner</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Robbins</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Dragic</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Romanovsky</surname> <given-names>AA</given-names></name>. <article-title>Thermoregulatory responses to lipopolysaccharide in the mouse: dependence on the dose and ambient temperature</article-title>. <source>Am J Physiol Regul Integr Comp Physiol</source>. <year>2005</year>;<volume>289</volume>(<issue>5</issue>):<fpage>R1244</fpage>–<lpage>52</lpage>. Epub 2005/08/06. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpregu.00370.2005" xlink:type="simple">10.1152/ajpregu.00370.2005</ext-link></comment> <object-id pub-id-type="pmid">16081879</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Everhardt Queen</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Moerdyk-Schauwecker</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>McKee</surname> <given-names>LM</given-names></name>, <name name-style="western"><surname>Leamy</surname> <given-names>LJ</given-names></name>, <name name-style="western"><surname>Huet</surname> <given-names>YM</given-names></name>. <article-title>Differential Expression of Inflammatory Cytokines and Stress Genes in Male and Female Mice in Response to a Lipopolysaccharide Challenge</article-title>. <source>PLoS ONE</source>. <year>2016</year>;<volume>11</volume>(<issue>4</issue>):<fpage>e0152289</fpage>. Epub 2016/04/28. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0152289" xlink:type="simple">10.1371/journal.pone.0152289</ext-link></comment> <object-id pub-id-type="pmid">27120355</object-id>; PubMed Central PMCID: PMCPMC4847773.</mixed-citation></ref>
<ref id="pbio.3000161.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Nguyen</surname> <given-names>HG</given-names></name>, <name name-style="western"><surname>Koupenova</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Chauhan</surname> <given-names>AK</given-names></name>, <name name-style="western"><surname>Makitalo</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>The A2B adenosine receptor protects against inflammation and excessive vascular adhesion</article-title>. <source>J Clin Invest</source>. <year>2006</year>;<volume>116</volume>(<issue>7</issue>):<fpage>1913</fpage>–<lpage>23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/JCI27933" xlink:type="simple">10.1172/JCI27933</ext-link></comment> <object-id pub-id-type="pmid">16823489</object-id>; PubMed Central PMCID: PMCPMC1483170.</mixed-citation></ref>
<ref id="pbio.3000161.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hasko</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Kuhel</surname> <given-names>DG</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Schwarzschild</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Deitch</surname> <given-names>EA</given-names></name>, <name name-style="western"><surname>Mabley</surname> <given-names>JG</given-names></name>, <etal>et al</etal>. <article-title>Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms</article-title>. <source>FASEB J</source>. <year>2000</year>;<volume>14</volume>(<issue>13</issue>):<fpage>2065</fpage>–<lpage>74</lpage>. Epub 2000/10/12. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1096/fj.99-0508com" xlink:type="simple">10.1096/fj.99-0508com</ext-link></comment> <object-id pub-id-type="pmid">11023991</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Kaasik</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Blackburn</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>CC</given-names></name>. <article-title>Constant darkness is a circadian metabolic signal in mammals</article-title>. <source>Nature</source>. <year>2006</year>;<volume>439</volume>(<issue>7074</issue>):<fpage>340</fpage>–<lpage>3</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature04368" xlink:type="simple">10.1038/nature04368</ext-link></comment> <object-id pub-id-type="pmid">16421573</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Swoap</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Rathvon</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Gutilla</surname> <given-names>M</given-names></name>. <article-title>AMP does not induce torpor</article-title>. <source>Am J Physiol Regul Integr Comp Physiol</source>. <year>2007</year>;<volume>293</volume>(<issue>1</issue>):<fpage>R468</fpage>–<lpage>73</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpregu.00888.2006" xlink:type="simple">10.1152/ajpregu.00888.2006</ext-link></comment> <object-id pub-id-type="pmid">17409259</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rittiner</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Korboukh</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Hull-Ryde</surname> <given-names>EA</given-names></name>, <name name-style="western"><surname>Jin</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Janzen</surname> <given-names>WP</given-names></name>, <name name-style="western"><surname>Frye</surname> <given-names>SV</given-names></name>, <etal>et al</etal>. <article-title>AMP is an adenosine A1 receptor agonist</article-title>. <source>J Biol Chem</source>. <year>2012</year>;<volume>287</volume>(<issue>8</issue>):<fpage>5301</fpage>–<lpage>9</lpage>. Epub 2012/01/05. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M111.291666" xlink:type="simple">10.1074/jbc.M111.291666</ext-link></comment> M111.291666 [pii]. <object-id pub-id-type="pmid">22215671</object-id>; PubMed Central PMCID: PMC3285310.</mixed-citation></ref>
<ref id="pbio.3000161.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Daniels</surname> <given-names>IS</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>O'Brien</surname> <given-names>WG</given-names> <suffix>3rd</suffix></name>, <name name-style="western"><surname>Tao</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Miki</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Zhao</surname> <given-names>Z</given-names></name>, <etal>et al</etal>. <article-title>A role of erythrocytes in adenosine monophosphate initiation of hypometabolism in mammals</article-title>. <source>The Journal of biological chemistry</source>. <year>2010</year>;<volume>285</volume>(<issue>27</issue>):<fpage>20716</fpage>–<lpage>23</lpage>. Epub 2010/05/01. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M109.090845" xlink:type="simple">10.1074/jbc.M109.090845</ext-link></comment> <object-id pub-id-type="pmid">20430891</object-id>; PubMed Central PMCID: PMC2898302.</mixed-citation></ref>
<ref id="pbio.3000161.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>O'Brien</surname> <given-names>WG</given-names> <suffix>3rd</suffix></name>, <name name-style="western"><surname>Ling</surname> <given-names>HS</given-names></name>, <name name-style="western"><surname>Zhao</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>CC</given-names></name>. <article-title>New insights on the regulation of the adenine nucleotide pool of erythrocytes in mouse models</article-title>. <source>PLoS ONE</source>. <year>2017</year>;<volume>12</volume>(<issue>7</issue>):<fpage>e0180948</fpage>. Epub 2017/07/27. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0180948" xlink:type="simple">10.1371/journal.pone.0180948</ext-link></comment> <object-id pub-id-type="pmid">28746349</object-id>; PubMed Central PMCID: PMCPMC5528878.</mixed-citation></ref>
<ref id="pbio.3000161.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eisner</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Grill</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Qin</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Hoerl</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Briggs</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Profound hypothermia after adenosine kinase inhibition in A1AR-deficient mice suggests a receptor-independent effect of intracellular adenosine</article-title>. <source>Pflugers Arch</source>. <year>2017</year>;<volume>469</volume>(<issue>2</issue>):<fpage>339</fpage>–<lpage>47</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00424-016-1925-3" xlink:type="simple">10.1007/s00424-016-1925-3</ext-link></comment> <object-id pub-id-type="pmid">27975140</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McGaraughty</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Chu</surname> <given-names>KL</given-names></name>, <name name-style="western"><surname>Wismer</surname> <given-names>CT</given-names></name>, <name name-style="western"><surname>Mikusa</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>CZ</given-names></name>, <name name-style="western"><surname>Cowart</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Effects of A-134974, a novel adenosine kinase inhibitor, on carrageenan-induced inflammatory hyperalgesia and locomotor activity in rats: evaluation of the sites of action</article-title>. <source>J Pharmacol Exp Ther</source>. <year>2001</year>;<volume>296</volume>(<issue>2</issue>):<fpage>501</fpage>–<lpage>9</lpage>. Epub 2001/02/13. <object-id pub-id-type="pmid">11160637</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fredholm BB</surname></name>, <name name-style="western"><surname>AP</surname> <given-names>IJ</given-names></name>, <name name-style="western"><surname>Jacobson</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Linden</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Muller</surname> <given-names>CE</given-names></name>. <article-title>International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors—an update</article-title>. <source>Pharmacol Rev</source>. <year>2011</year>;<volume>63</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>34</lpage>. Epub 2011/02/10. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1124/pr.110.003285" xlink:type="simple">10.1124/pr.110.003285</ext-link></comment> pr.110.003285 [pii]. <object-id pub-id-type="pmid">21303899</object-id>; PubMed Central PMCID: PMC3061413.</mixed-citation></ref>
<ref id="pbio.3000161.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alnouri</surname> <given-names>MW</given-names></name>, <name name-style="western"><surname>Jepards</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Casari</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Schiedel</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Hinz</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Muller</surname> <given-names>CE</given-names></name>. <article-title>Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors</article-title>. <source>Purinergic Signal</source>. <year>2015</year>;<volume>11</volume>(<issue>3</issue>):<fpage>389</fpage>–<lpage>407</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11302-015-9460-9" xlink:type="simple">10.1007/s11302-015-9460-9</ext-link></comment> <object-id pub-id-type="pmid">26126429</object-id>; PubMed Central PMCID: PMCPMC4529847.</mixed-citation></ref>
<ref id="pbio.3000161.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname> <given-names>JN</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Fredholm</surname> <given-names>BB</given-names></name>. <article-title>Physiological roles of A1 and A2A adenosine receptors in regulating heart rate, body temperature, and locomotion as revealed using knockout mice and caffeine</article-title>. <source>Am J Physiol Heart Circ Physiol</source>. <year>2009</year>;<volume>296</volume>(<issue>4</issue>):<fpage>H1141</fpage>–<lpage>9</lpage>. Epub 2009/02/17. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpheart.00754.2008" xlink:type="simple">10.1152/ajpheart.00754.2008</ext-link></comment> 00754.2008 [pii]. <object-id pub-id-type="pmid">19218506</object-id>; PubMed Central PMCID: PMC2670688.</mixed-citation></ref>
<ref id="pbio.3000161.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jin</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Shepherd</surname> <given-names>RK</given-names></name>, <name name-style="western"><surname>Duling</surname> <given-names>BR</given-names></name>, <name name-style="western"><surname>Linden</surname> <given-names>J</given-names></name>. <article-title>Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation</article-title>. <source>J Clin Invest</source>. <year>1997</year>;<volume>100</volume>(<issue>11</issue>):<fpage>2849</fpage>–<lpage>57</lpage>. Epub 1998/02/12. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/JCI119833" xlink:type="simple">10.1172/JCI119833</ext-link></comment> <object-id pub-id-type="pmid">9389751</object-id>; PubMed Central PMCID: PMCPMC508491.</mixed-citation></ref>
<ref id="pbio.3000161.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gomez</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Sitkovsky</surname> <given-names>MV</given-names></name>. <article-title>Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo</article-title>. <source>Blood</source>. <year>2003</year>;<volume>102</volume>(<issue>13</issue>):<fpage>4472</fpage>–<lpage>8</lpage>. Epub 2003/08/30. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1182/blood-2002-11-3624" xlink:type="simple">10.1182/blood-2002-11-3624</ext-link></comment> <object-id pub-id-type="pmid">12947007</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ward</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Sherali</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Mo</surname> <given-names>ZP</given-names></name>, <name name-style="western"><surname>Tse</surname> <given-names>CM</given-names></name>. <article-title>Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine</article-title>. <source>J Biol Chem</source>. <year>2000</year>;<volume>275</volume>(<issue>12</issue>):<fpage>8375</fpage>–<lpage>81</lpage>. Epub 2000/03/18. <object-id pub-id-type="pmid">10722669</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nagai</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Nagasawa</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Fujimoto</surname> <given-names>S</given-names></name>. <article-title>Transport mechanisms for adenosine and uridine in primary-cultured rat cortical neurons and astrocytes</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2005</year>;<volume>334</volume>(<issue>4</issue>):<fpage>1343</fpage>–<lpage>50</lpage>. Epub 2005/07/27. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bbrc.2005.07.032" xlink:type="simple">10.1016/j.bbrc.2005.07.032</ext-link></comment> <object-id pub-id-type="pmid">16043124</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Deng</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>ZV</given-names></name>, <name name-style="western"><surname>Gordillo</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>An</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Liang</surname> <given-names>Q</given-names></name>, <etal>et al</etal>. <article-title>An adipo-biliary-uridine axis that regulates energy homeostasis</article-title>. <source>Science</source>. <year>2017</year>;<volume>355</volume>(<issue>6330</issue>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.aaf5375" xlink:type="simple">10.1126/science.aaf5375</ext-link></comment> <object-id pub-id-type="pmid">28302796</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Peters</surname> <given-names>GJ</given-names></name>, <name name-style="western"><surname>van Groeningen</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Laurensse</surname> <given-names>EJ</given-names></name>, <name name-style="western"><surname>Lankelma</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Leyva</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Pinedo</surname> <given-names>HM</given-names></name>. <article-title>Uridine-induced hypothermia in mice and rats in relation to plasma and tissue levels of uridine and its metabolites</article-title>. <source>Cancer Chemother Pharmacol</source>. <year>1987</year>;<volume>20</volume>(<issue>2</issue>):<fpage>101</fpage>–<lpage>8</lpage>. <object-id pub-id-type="pmid">3664929</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Freinkel</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Metzger</surname> <given-names>BE</given-names></name>, <name name-style="western"><surname>Harris</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Robinson</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Mager</surname> <given-names>M</given-names></name>. <article-title>The hypothermia of hypoglycemia. Studies with 2-deoxy-D-glucose in normal human subjects and mice</article-title>. <source>N Engl J Med</source>. <year>1972</year>;<volume>287</volume>(<issue>17</issue>):<fpage>841</fpage>–<lpage>5</lpage>. Epub 1972/10/26. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJM197210262871702" xlink:type="simple">10.1056/NEJM197210262871702</ext-link></comment> <object-id pub-id-type="pmid">5071962</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lam</surname> <given-names>TK</given-names></name>, <name name-style="western"><surname>Pocai</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Gutierrez-Juarez</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Obici</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Bryan</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Aguilar-Bryan</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis</article-title>. <source>Nat Med</source>. <year>2005</year>;<volume>11</volume>(<issue>3</issue>):<fpage>320</fpage>–<lpage>7</lpage>. Epub 2005/03/01. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nm1201" xlink:type="simple">10.1038/nm1201</ext-link></comment> <object-id pub-id-type="pmid">15735652</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lam</surname> <given-names>TK</given-names></name>, <name name-style="western"><surname>Gutierrez-Juarez</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Pocai</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Rossetti</surname> <given-names>L</given-names></name>. <article-title>Regulation of blood glucose by hypothalamic pyruvate metabolism</article-title>. <source>Science</source>. <year>2005</year>;<volume>309</volume>(<issue>5736</issue>):<fpage>943</fpage>–<lpage>7</lpage>. Epub 2005/08/06. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.1112085" xlink:type="simple">10.1126/science.1112085</ext-link></comment> <object-id pub-id-type="pmid">16081739</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pedata</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Dettori</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Coppi</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Melani</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Fusco</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Corradetti</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Purinergic signalling in brain ischemia</article-title>. <source>Neuropharmacology</source>. <year>2016</year>;<volume>104</volume>:<fpage>105</fpage>–<lpage>30</lpage>. Epub 2015/11/20. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.neuropharm.2015.11.007" xlink:type="simple">10.1016/j.neuropharm.2015.11.007</ext-link></comment> <object-id pub-id-type="pmid">26581499</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mayne</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Shepel</surname> <given-names>PN</given-names></name>, <name name-style="western"><surname>Jiang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Geiger</surname> <given-names>JD</given-names></name>, <name name-style="western"><surname>Power</surname> <given-names>C</given-names></name>. <article-title>Dysregulation of adenosine A1 receptor-mediated cytokine expression in peripheral blood mononuclear cells from multiple sclerosis patients</article-title>. <source>Ann Neurol</source>. <year>1999</year>;<volume>45</volume>(<issue>5</issue>):<fpage>633</fpage>–<lpage>9</lpage>. Epub 1999/05/13. <object-id pub-id-type="pmid">10319886</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moser</surname> <given-names>GH</given-names></name>, <name name-style="western"><surname>Schrader</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Deussen</surname> <given-names>A</given-names></name>. <article-title>Turnover of adenosine in plasma of human and dog blood</article-title>. <source>Am J Physiol</source>. <year>1989</year>;<volume>256</volume>(<issue>4</issue> Pt 1):<fpage>C799</fpage>–<lpage>806</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpcell.1989.256.4.C799" xlink:type="simple">10.1152/ajpcell.1989.256.4.C799</ext-link></comment> <object-id pub-id-type="pmid">2539728</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Blardi</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Laghi Pasini</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Urso</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Frigerio</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Volpi</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>De Giorgi</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Pharmacokinetics of exogenous adenosine in man after infusion</article-title>. <source>Eur J Clin Pharmacol</source>. <year>1993</year>;<volume>44</volume>(<issue>5</issue>):<fpage>505</fpage>–<lpage>7</lpage>. Epub 1993/01/01. <object-id pub-id-type="pmid">8359193</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vecchio</surname> <given-names>EA</given-names></name>, <name name-style="western"><surname>Baltos</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Nguyen</surname> <given-names>ATN</given-names></name>, <name name-style="western"><surname>Christopoulos</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>White</surname> <given-names>PJ</given-names></name>, <name name-style="western"><surname>May</surname> <given-names>LT</given-names></name>. <article-title>New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism</article-title>. <source>Br J Pharmacol</source>. <year>2018</year>;<volume>175</volume>(<issue>21</issue>):<fpage>4036</fpage>–<lpage>46</lpage>. Epub 2018/04/22. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/bph.14337" xlink:type="simple">10.1111/bph.14337</ext-link></comment> <object-id pub-id-type="pmid">29679502</object-id>; PubMed Central PMCID: PMCPMC6177620.</mixed-citation></ref>
<ref id="pbio.3000161.ref057"><label>57</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hasko</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Sitkovsky</surname> <given-names>MV</given-names></name>, <name name-style="western"><surname>Szabo</surname> <given-names>C</given-names></name>. <article-title>Immunomodulatory and neuroprotective effects of inosine</article-title>. <source>Trends Pharmacol Sci</source>. <year>2004</year>;<volume>25</volume>(<issue>3</issue>):<fpage>152</fpage>–<lpage>7</lpage>. Epub 2004/03/17. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.tips.2004.01.006" xlink:type="simple">10.1016/j.tips.2004.01.006</ext-link></comment> <object-id pub-id-type="pmid">15019271</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref058"><label>58</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tilley</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Wagoner</surname> <given-names>VA</given-names></name>, <name name-style="western"><surname>Salvatore</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Jacobson</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Koller</surname> <given-names>BH</given-names></name>. <article-title>Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells</article-title>. <source>J Clin Invest</source>. <year>2000</year>;<volume>105</volume>(<issue>3</issue>):<fpage>361</fpage>–<lpage>7</lpage>. Epub 2000/02/17. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/JCI8253" xlink:type="simple">10.1172/JCI8253</ext-link></comment> <object-id pub-id-type="pmid">10675362</object-id>; PubMed Central PMCID: PMCPMC377446.</mixed-citation></ref>
<ref id="pbio.3000161.ref059"><label>59</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fredholm</surname> <given-names>BB</given-names></name>, <name name-style="western"><surname>Irenius</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Kull</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Schulte</surname> <given-names>G</given-names></name>. <article-title>Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells</article-title>. <source>Biochem Pharmacol</source>. <year>2001</year>;<volume>61</volume>(<issue>4</issue>):<fpage>443</fpage>–<lpage>8</lpage>. Epub 2001/02/28. <object-id pub-id-type="pmid">11226378</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref060"><label>60</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Welihinda</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Kaur</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Raveendran</surname> <given-names>KS</given-names></name>, <name name-style="western"><surname>Amento</surname> <given-names>EP</given-names></name>. <article-title>Enhancement of inosine-mediated A2AR signaling through positive allosteric modulation</article-title>. <source>Cell Signal</source>. <year>2018</year>;<volume>42</volume>:<fpage>227</fpage>–<lpage>35</lpage>. Epub 2017/11/12. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cellsig.2017.11.002" xlink:type="simple">10.1016/j.cellsig.2017.11.002</ext-link></comment> <object-id pub-id-type="pmid">29126977</object-id>; PubMed Central PMCID: PMCPMC5732040.</mixed-citation></ref>
<ref id="pbio.3000161.ref061"><label>61</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Welihinda</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Kaur</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Greene</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Zhai</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Amento</surname> <given-names>EP</given-names></name>. <article-title>The adenosine metabolite inosine is a functional agonist of the adenosine A2A receptor with a unique signaling bias</article-title>. <source>Cell Signal</source>. <year>2016</year>;<volume>28</volume>(<issue>6</issue>):<fpage>552</fpage>–<lpage>60</lpage>. Epub 2016/02/24. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cellsig.2016.02.010" xlink:type="simple">10.1016/j.cellsig.2016.02.010</ext-link></comment> <object-id pub-id-type="pmid">26903141</object-id>; PubMed Central PMCID: PMCPMC4826793.</mixed-citation></ref>
<ref id="pbio.3000161.ref062"><label>62</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Doyle</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Cristofaro</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Sack</surname> <given-names>BS</given-names></name>, <name name-style="western"><surname>Lukianov</surname> <given-names>SN</given-names></name>, <name name-style="western"><surname>Schafer</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Chung</surname> <given-names>YG</given-names></name>, <etal>et al</etal>. <article-title>Inosine attenuates spontaneous activity in the rat neurogenic bladder through an A2B pathway</article-title>. <source>Sci Rep</source>. <year>2017</year>;<volume>7</volume>:<fpage>44416</fpage>. Epub 2017/03/16. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/srep44416" xlink:type="simple">10.1038/srep44416</ext-link></comment> <object-id pub-id-type="pmid">28294142</object-id>; PubMed Central PMCID: PMCPMC5353659.</mixed-citation></ref>
<ref id="pbio.3000161.ref063"><label>63</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Daly</surname> <given-names>JW</given-names></name>. <article-title>Caffeine analogs: biomedical impact</article-title>. <source>Cell Mol Life Sci</source>. <year>2007</year>;<volume>64</volume>(<issue>16</issue>):<fpage>2153</fpage>–<lpage>69</lpage>. Epub 2007/05/22. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00018-007-7051-9" xlink:type="simple">10.1007/s00018-007-7051-9</ext-link></comment> <object-id pub-id-type="pmid">17514358</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref064"><label>64</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duan</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Slaughter</surname> <given-names>MM</given-names></name>. <article-title>Caffeine inhibition of ionotropic glycine receptors</article-title>. <source>J Physiol</source>. <year>2009</year>;<volume>587</volume>(<issue>Pt 16</issue>):<fpage>4063</fpage>–<lpage>75</lpage>. Epub 2009/07/01. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1113/jphysiol.2009.174797" xlink:type="simple">10.1113/jphysiol.2009.174797</ext-link></comment> <object-id pub-id-type="pmid">19564396</object-id>; PubMed Central PMCID: PMCPMC2756438.</mixed-citation></ref>
<ref id="pbio.3000161.ref065"><label>65</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zucchi</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Ronca-Testoni</surname> <given-names>S</given-names></name>. <article-title>The sarcoplasmic reticulum Ca2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states</article-title>. <source>Pharmacol Rev</source>. <year>1997</year>;<volume>49</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>51</lpage>. Epub 1997/03/01. <object-id pub-id-type="pmid">9085308</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref066"><label>66</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bonati</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Latini</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Tognoni</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Young</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Garattini</surname> <given-names>S</given-names></name>. <article-title>Interspecies comparison of in vivo caffeine pharmacokinetics in man, monkey, rabbit, rat, and mouse</article-title>. <source>Drug Metab Rev</source>. <year>1984</year>;<volume>15</volume>(<issue>7</issue>):<fpage>1355</fpage>–<lpage>83</lpage>. Epub 1984/01/01. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3109/03602538409029964" xlink:type="simple">10.3109/03602538409029964</ext-link></comment> <object-id pub-id-type="pmid">6543526</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref067"><label>67</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huang</surname> <given-names>ZL</given-names></name>, <name name-style="western"><surname>Qu</surname> <given-names>WM</given-names></name>, <name name-style="western"><surname>Eguchi</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Schwarzschild</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Fredholm</surname> <given-names>BB</given-names></name>, <etal>et al</etal>. <article-title>Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine</article-title>. <source>Nat Neurosci</source>. <year>2005</year>;<volume>8</volume>(<issue>7</issue>):<fpage>858</fpage>–<lpage>9</lpage>. Epub 2005/06/21. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nn1491" xlink:type="simple">10.1038/nn1491</ext-link></comment> <object-id pub-id-type="pmid">15965471</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref068"><label>68</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>El Yacoubi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ledent</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Menard</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Parmentier</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Costentin</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Vaugeois</surname> <given-names>JM</given-names></name>. <article-title>The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors</article-title>. <source>British journal of pharmacology</source>. <year>2000</year>;<volume>129</volume>(<issue>7</issue>):<fpage>1465</fpage>–<lpage>73</lpage>. Epub 2000/04/01. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/sj.bjp.0703170" xlink:type="simple">10.1038/sj.bjp.0703170</ext-link></comment> <object-id pub-id-type="pmid">10742303</object-id>; PubMed Central PMCID: PMC1571962.</mixed-citation></ref>
<ref id="pbio.3000161.ref069"><label>69</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bettio</surname> <given-names>LE</given-names></name>, <name name-style="western"><surname>Gil-Mohapel</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Rodrigues</surname> <given-names>AL</given-names></name>. <article-title>Guanosine and its role in neuropathologies</article-title>. <source>Purinergic Signal</source>. <year>2016</year>;<volume>12</volume>(<issue>3</issue>):<fpage>411</fpage>–<lpage>26</lpage>. Epub 2016/03/24. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11302-016-9509-4" xlink:type="simple">10.1007/s11302-016-9509-4</ext-link></comment> <object-id pub-id-type="pmid">27002712</object-id>; PubMed Central PMCID: PMCPMC5023624.</mixed-citation></ref>
<ref id="pbio.3000161.ref070"><label>70</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Soares</surname> <given-names>FA</given-names></name>, <name name-style="western"><surname>Schmidt</surname> <given-names>AP</given-names></name>, <name name-style="western"><surname>Farina</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Frizzo</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Tavares</surname> <given-names>RG</given-names></name>, <name name-style="western"><surname>Portela</surname> <given-names>LV</given-names></name>, <etal>et al</etal>. <article-title>Anticonvulsant effect of GMP depends on its conversion to guanosine</article-title>. <source>Brain Res</source>. <year>2004</year>;<volume>1005</volume>(<issue>1–2</issue>):<fpage>182</fpage>–<lpage>6</lpage>. Epub 2004/03/27. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.brainres.2004.01.053" xlink:type="simple">10.1016/j.brainres.2004.01.053</ext-link></comment> <object-id pub-id-type="pmid">15044076</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref071"><label>71</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lakatos</surname> <given-names>RK</given-names></name>, <name name-style="western"><surname>Dobolyi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Todorov</surname> <given-names>MI</given-names></name>, <name name-style="western"><surname>Kekesi</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Juhasz</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Aleksza</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Guanosine may increase absence epileptic activity by means of A2A adenosine receptors in Wistar Albino Glaxo Rijswijk rats</article-title>. <source>Brain Res Bull</source>. <year>2016</year>;<volume>124</volume>:<fpage>172</fpage>–<lpage>81</lpage>. Epub 2016/05/08. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.brainresbull.2016.05.001" xlink:type="simple">10.1016/j.brainresbull.2016.05.001</ext-link></comment> <object-id pub-id-type="pmid">27154620</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref072"><label>72</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>van Galen</surname> <given-names>PJ</given-names></name>, <name name-style="western"><surname>van Bergen</surname> <given-names>AH</given-names></name>, <name name-style="western"><surname>Gallo-Rodriguez</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Melman</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Olah</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>AP</surname> <given-names>IJ</given-names></name>, <etal>et al</etal>. <article-title>A binding site model and structure-activity relationships for the rat A3 adenosine receptor</article-title>. <source>Mol Pharmacol</source>. <year>1994</year>;<volume>45</volume>(<issue>6</issue>):<fpage>1101</fpage>–<lpage>11</lpage>. Epub 1994/06/01. <object-id pub-id-type="pmid">8022403</object-id>; PubMed Central PMCID: PMCPMC3479652.</mixed-citation></ref>
<ref id="pbio.3000161.ref073"><label>73</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Miller</surname> <given-names>RL</given-names></name>, <name name-style="western"><surname>Adamczyk</surname> <given-names>DL</given-names></name>, <name name-style="western"><surname>Miller</surname> <given-names>WH</given-names></name>, <name name-style="western"><surname>Koszalka</surname> <given-names>GW</given-names></name>, <name name-style="western"><surname>Rideout</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Beacham</surname> <given-names>LM</given-names> <suffix>3rd</suffix></name>, <etal>et al</etal>. <article-title>Adenosine kinase from rabbit liver. II. Substrate and inhibitor specificity</article-title>. <source>J Biol Chem</source>. <year>1979</year>;<volume>254</volume>(<issue>7</issue>):<fpage>2346</fpage>–<lpage>52</lpage>. Epub 1979/04/10. <object-id pub-id-type="pmid">218934</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref074"><label>74</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wiginton</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Coleman</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Hutton</surname> <given-names>JJ</given-names></name>. <article-title>Purification, characterization and radioimmunoassay of adenosine deaminase from human leukaemic granulocytes</article-title>. <source>Biochem J</source>. <year>1981</year>;<volume>195</volume>(<issue>2</issue>):<fpage>389</fpage>–<lpage>97</lpage>. Epub 1981/05/01. <object-id pub-id-type="pmid">6947796</object-id>; PubMed Central PMCID: PMCPMC1162902.</mixed-citation></ref>
<ref id="pbio.3000161.ref075"><label>75</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dobolyi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Juhasz</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Kovacs</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Kardos</surname> <given-names>J</given-names></name>. <article-title>Uridine function in the central nervous system</article-title>. <source>Curr Top Med Chem</source>. <year>2011</year>;<volume>11</volume>(<issue>8</issue>):<fpage>1058</fpage>–<lpage>67</lpage>. Epub 2011/03/16. <object-id pub-id-type="pmid">21401495</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref076"><label>76</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Williams-Karnesky</surname> <given-names>RL</given-names></name>, <name name-style="western"><surname>Sandau</surname> <given-names>US</given-names></name>, <name name-style="western"><surname>Lusardi</surname> <given-names>TA</given-names></name>, <name name-style="western"><surname>Lytle</surname> <given-names>NK</given-names></name>, <name name-style="western"><surname>Farrell</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Pritchard</surname> <given-names>EM</given-names></name>, <etal>et al</etal>. <article-title>Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis</article-title>. <source>J Clin Invest</source>. <year>2013</year>;<volume>123</volume>(<issue>8</issue>):<fpage>3552</fpage>–<lpage>63</lpage>. Epub 2013/07/19. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/JCI65636" xlink:type="simple">10.1172/JCI65636</ext-link></comment> <object-id pub-id-type="pmid">23863710</object-id>; PubMed Central PMCID: PMCPMC3726154.</mixed-citation></ref>
<ref id="pbio.3000161.ref077"><label>77</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rodrigues</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Marques</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Cunha</surname> <given-names>RA</given-names></name>. <article-title>Purinergic signalling and brain development</article-title>. <source>Semin Cell Dev Biol</source>. <year>2019</year>:<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.semcdb.2018.12.001" xlink:type="simple">https://doi.org/10.1016/j.semcdb.2018.12.001</ext-link>. Epub 2018/12/12. <object-id pub-id-type="pmid">30529149</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref078"><label>78</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rivkees</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Wendler</surname> <given-names>CC</given-names></name>. <article-title>Long-term consequences of disrupting adenosine signaling during embryonic development</article-title>. <source>Mol Aspects Med</source>. <year>2017</year>;<volume>55</volume>:<fpage>110</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.mam.2017.02.001" xlink:type="simple">10.1016/j.mam.2017.02.001</ext-link></comment> <object-id pub-id-type="pmid">28202385</object-id>; PubMed Central PMCID: PMCPMC5487283.</mixed-citation></ref>
<ref id="pbio.3000161.ref079"><label>79</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Podzuweit</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Nennstiel</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Muller</surname> <given-names>A</given-names></name>. <article-title>Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine</article-title>. <source>Cell Signal</source>. <year>1995</year>;<volume>7</volume>(<issue>7</issue>):<fpage>733</fpage>–<lpage>8</lpage>. Epub 1995/09/01. <object-id pub-id-type="pmid">8519602</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref080"><label>80</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liaudet</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Mabley</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Pacher</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Virag</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Soriano</surname> <given-names>FG</given-names></name>, <name name-style="western"><surname>Marton</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Inosine exerts a broad range of antiinflammatory effects in a murine model of acute lung injury</article-title>. <source>Ann Surg</source>. <year>2002</year>;<volume>235</volume>(<issue>4</issue>):<fpage>568</fpage>–<lpage>78</lpage>. Epub 2002/03/30. <object-id pub-id-type="pmid">11923614</object-id>; PubMed Central PMCID: PMCPMC1422473.</mixed-citation></ref>
<ref id="pbio.3000161.ref081"><label>81</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lute</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Jou</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Lateef</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Goldgof</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Xiao</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Pinol</surname> <given-names>RA</given-names></name>, <etal>et al</etal>. <article-title>Biphasic effect of melanocortin agonists on metabolic rate and body temperature</article-title>. <source>Cell Metab</source>. <year>2014</year>;<volume>20</volume>(<issue>2</issue>):<fpage>333</fpage>–<lpage>45</lpage>. Epub 2014/07/02. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cmet.2014.05.021" xlink:type="simple">10.1016/j.cmet.2014.05.021</ext-link></comment> <object-id pub-id-type="pmid">24981835</object-id>; PubMed Central PMCID: PMC4126889.</mixed-citation></ref>
<ref id="pbio.3000161.ref082"><label>82</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Eisner</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Faulhaber-Walter</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Mizel</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Wall</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Briggs</surname> <given-names>JP</given-names></name>, <etal>et al</etal>. <article-title>Salt sensitivity of blood pressure in NKCC1-deficient mice</article-title>. <source>Am J Physiol Renal Physiol</source>. <year>2008</year>;<volume>295</volume>(<issue>4</issue>):<fpage>F1230</fpage>–<lpage>8</lpage>. Epub 2008/08/15. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajprenal.90392.2008" xlink:type="simple">10.1152/ajprenal.90392.2008</ext-link></comment> 90392.2008 [pii]. <object-id pub-id-type="pmid">18701622</object-id>; PubMed Central PMCID: PMC2576156.</mixed-citation></ref>
<ref id="pbio.3000161.ref083"><label>83</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Copeland</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Warren</surname> <given-names>HS</given-names></name>, <name name-style="western"><surname>Lowry</surname> <given-names>SF</given-names></name>, <name name-style="western"><surname>Calvano</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Remick</surname> <given-names>D</given-names></name>, Inflammation, <etal>et al</etal>. <article-title>Acute inflammatory response to endotoxin in mice and humans</article-title>. <source>Clin Diagn Lab Immunol</source>. <year>2005</year>;<volume>12</volume>(<issue>1</issue>):<fpage>60</fpage>–<lpage>7</lpage>. Epub 2005/01/12. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/CDLI.12.1.60-67.2005" xlink:type="simple">10.1128/CDLI.12.1.60-67.2005</ext-link></comment> <object-id pub-id-type="pmid">15642986</object-id>; PubMed Central PMCID: PMCPMC540200.</mixed-citation></ref>
<ref id="pbio.3000161.ref084"><label>84</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gewirtz</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Brown</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Most</surname> <given-names>AS</given-names></name>. <article-title>Measurement of plasma adenosine concentration: methodological and physiological considerations</article-title>. <source>Proc Soc Exp Biol Med</source>. <year>1987</year>;<volume>185</volume>(<issue>1</issue>):<fpage>93</fpage>–<lpage>100</lpage>. Epub 1987/05/01. <object-id pub-id-type="pmid">3554257</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref085"><label>85</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shryock</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Boykin</surname> <given-names>MT</given-names></name>, <name name-style="western"><surname>Hill</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Belardinelli</surname> <given-names>L</given-names></name>. <article-title>A new method of sampling blood for measurement of plasma adenosine</article-title>. <source>Am J Physiol</source>. <year>1990</year>;<volume>258</volume>(<issue>4</issue> Pt 2):<fpage>H1232</fpage>–<lpage>9</lpage>. Epub 1990/04/01. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpheart.1990.258.4.H1232" xlink:type="simple">10.1152/ajpheart.1990.258.4.H1232</ext-link></comment> <object-id pub-id-type="pmid">2331011</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref086"><label>86</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Veras</surname> <given-names>FP</given-names></name>, <name name-style="western"><surname>Peres</surname> <given-names>RS</given-names></name>, <name name-style="western"><surname>Saraiva</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Pinto</surname> <given-names>LG</given-names></name>, <name name-style="western"><surname>Louzada-Junior</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Cunha</surname> <given-names>TM</given-names></name>, <etal>et al</etal>. <article-title>Fructose 1,6-bisphosphate, a high-energy intermediate of glycolysis, attenuates experimental arthritis by activating anti-inflammatory adenosinergic pathway</article-title>. <source>Sci Rep</source>. <year>2015</year>;<volume>5</volume>:<fpage>15171</fpage>. Epub 2015/10/20. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/srep15171" xlink:type="simple">10.1038/srep15171</ext-link></comment> <object-id pub-id-type="pmid">26478088</object-id>; PubMed Central PMCID: PMCPMC4609967.</mixed-citation></ref>
<ref id="pbio.3000161.ref087"><label>87</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Slowiaczek</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Tattersall</surname> <given-names>MH</given-names></name>. <article-title>The determination of purine levels in human and mouse plasma</article-title>. <source>Anal Biochem</source>. <year>1982</year>;<volume>125</volume>(<issue>1</issue>):<fpage>6</fpage>–<lpage>12</lpage>. Epub 1982/09/01. <object-id pub-id-type="pmid">6897341</object-id>.</mixed-citation></ref>
<ref id="pbio.3000161.ref088"><label>88</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xiao</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Pinol</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Carlin</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Deng</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Gavrilova</surname> <given-names>O</given-names></name>, <etal>et al</etal>. <article-title>Bombesin-like receptor 3 (Brs3) expression in glutamatergic, but not GABAergic, neurons is required for regulation of energy metabolism</article-title>. <source>Mol Metab</source>. <year>2017</year>;<volume>6</volume>(<issue>11</issue>):<fpage>1540</fpage>–<lpage>50</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molmet.2017.08.013" xlink:type="simple">10.1016/j.molmet.2017.08.013</ext-link></comment> <object-id pub-id-type="pmid">29107299</object-id>; PubMed Central PMCID: PMCPMC5681273.</mixed-citation></ref>
</ref-list>
</back>
</article>